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ABSTRACT

EV ALUATION OF BONE QUALITY USING NOVEL IMAGE ANALYSES AND
MECHANICAL TESTING METHODS
QianXu

Osteoporosis has become a growing health threat with rising social and economic
consequences. The understanding of the relationship between bone mechanical strength
and bone structural quality is important for the diagnosis of osteoporosis and the
evaluation of osteoporosis treatments.
A novel cancellous bone segmentation method was developed to separate
cancellous bone from cortical bone automatically. The segmentation was based on the
three-dimensional images. The basic idea of the method is that a contiguous threedimensional non-bone region that is located inside the whole bone region of interest can
be defined as the marrow region. Any bone material that is surrounded by the marrow
region is considered cancellous bone while bone that is outside of the marrow region is
cortical bone. This method is more objective, more accurate and more precise than a
manual method and an established computer method (Helterbrand method).
Twenty-four female Sprague-Dawley rats, 7-8 weeks old, were used in a study of
various osteoporosis drugs. After 8 weeks drug treatment, alendronate had more positive
effects on cancellous bone volume fraction than 17 p-EstradioI2, raloxifene and PTH.
IV

This striking result may be explained by the age of the rat model because the young
animals are still growing rapidly and it is possible that the ovariectomy (OVX) operation
results in higher remodeling rate in young animals. When an anti-resorptive drug is
given, the individuals with high baseline remodeling rate have more positive response
than those with low baseline remodeling rate.
120 female Sprague-Dawley rats, 5.5 months or 6 months old, were used in three
studies of experimental drugs. In the Pradama studies, sensitivity analyses and linear
regression analyses were conducted. Drug effect analyses were also conducted, but this
research did not focus on that.
A new mechanical indentation test was developed. The three-point breaking test
and the calculation of volume fraction were also established during the research. By
focusing on only Sham group and OVX group, the sensitivity analyses showed that these
three new methods were much more sensitive than more traditional methods
(Archimedes' density measurements and three-point bending tests).
The linear regression analyses were conducted to explore if the image processing
methods can be correlated to the mechanical test methods, such as indentation testing and
three-point breaking testing. The analyses showed that the volume fraction calculated
from image processing methods explained most of the bone strength, but not all. The R2
of the correlation between the indentation force and the cancellous bone volume fraction
(0.542) was a little lower than that between the indentation force and the whole bone
volume fraction (0.588). The correlations between the mechanical results from threepoint breaking testing and the volume fractions (cancellous bone and whole bone) were

v

in the range of 0.504

~

0.552. So it is better to combine both image analysis and

mechanical tests to understand osteoporosis in bone properties and structures.
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CHAPTER 1. INTRODUCTION

Bones are extremely dense connective tissues that, in various shapes, constitute
the skeleton. The principal functions of the skeleton are mechanical support and
protection, maintenance of calcium homeostasis and haematopoiesis in the bone marrow.
Bone must be stiff, so it can support loads, such as body weight, jumping and running,
etc, and protect the soft tissues, such as brain, heart and liver, etc. Bone must also
maintain a degree of elasticity, so it can deform slightly without cracking to absorb
energy when it is in compression or in tension.
There are two main forms of bone: one is cortical bone, also known as compact
bone; the other is cancellous bone, also known as trabecular bone or spongy bone (Figure
l-la). Cortical bone is dense, solid structure that plays an important role to the supportive
and protective function of the skeleton. It is found primary in the shaft of long bones and
forms the outer shell around cancellous bone at the ends of bones near joints and also in
the vertebrae. Cancellous bone fills the end of long bones and also makes up the majority
of vertebral bodies. Cancellous bone has honeycomb structure that consists of rods and
plates. It is believed to distribute and dissipate the energy from articular contact loads.
About 20% of the total skeletal mass in the adult human skeleton is cancellous bone and
about 80% of the total skeletal mass is cortical bone. However, cancellous bone has a
much greater surface area than cortical bone.
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Within the skeleton, cancellous bone

contributes about 67% of the total skeletal surface area in the adult human skeleton while
cortical bone contributes the remaining 33% (Bronner F et aI., 1999).

healthy bon€!

osleO(')OI0UC.

bone

a Thighbone
(femur)
b

(a) Diagram of bone structure

(b) comparison of healthy
bone and osteoporotic bone

Figure 1-1 Bone description

Bone is living, self-repairing tissue constantly being replaced and renewed. Old
bone is removed from the skeleton and new bone is added. Early in life, there is a
positive bone balance, that is, new bone is added faster than old bone is removed. As a
result, bones become larger, heavier, and denser, and the impact of bone loss related to
aging is reduced. By about age 30, bone reaches its maximum density and strength, or
"peak bone mass." After this peak, bone removal begins to outpace formation of new
bone, which, over time, leads to bone loss (Figure 1-2). In general, the older you are, the
lower the total bone mass and the greater the risk for osteoporosis. For women, the rate of
bone loss is greatest in the first few years after menopause. After that, bone loss
continues but more slowly. Because bone formation and bone loss only happen on the
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surface of bone, cancellous bone is lost much more rapidly than cortical bone when bone
turnover gets out of balance.
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Figure 1-2 Phases in the skeletal life cycle

Estrogen deficiency (e.g. , after menopause) increases the rate of remodeling and
the volume of bone that is resorbed by prolonging the life span of osteoclasts. It also
decreases the volume of bone that is formed by reducing the life span of osteoblasts,
thereby aggravating the negative bone balance in the bone multicellular unit (Manolagas
SC, 2000). It is why menopausal and post-menopausal women have accelerated bone loss
and bone structural decay.
Osteoporosis has been described as "a skeletal disease characterized by low bone
mass and micro architectural deterioration of bone tissue, with a consequent increase in
bone fragility and susceptibility to fracture" (Consensus Development Conference, 1991).
The deterioration of bone tissue is shown in different aspects, such as cortical bone
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becomes more porous and thinner, trabeculae are lost and penetrated, bone material
becomes more brittle, etc. The comparison of healthy bone and osteoporotic bone is
shown in Figure 1-1 b, in which the loss of bone mass in the osteoporotic bone is apparent
with perceptible changes in trabecular architecture. Osteoporosis is a progressive, chronic
disease with no symptoms until a bone fracture occurs. Generalized age-related bone loss
begins in men and women during their fifth decade, continues unabated through the
remainder of life, and ultimately is responsible for senile osteoporosis (Turner RT et aI.,
2001). With advancing age, any part of the skeleton can lose bone because of
osteoporosis, but not in equal amounts. When bone is not strong enough to support
mechanical loading, fractures occur.
In the United States, more than 1.5 million fractures occur due to osteoporosis

each year (Orsini LS et aI., 2005). The fractures lead to considerable pain, decreased
quality of life, loss of independence and mortality. Residual lifetime fracture risk in a
person aged 60 years with average life expectancy was 29% for males and 56% for
females (Jones G et aI., 1994). The study by Melton LJ et al (1997) shows that, above age
45, 70-80% of all distal radius fractures in women, and 40-45% of all radius fractures in
men are due to osteoporotic bone changes. Osteoporotic vertebral fractures are common
in the elderly, occurring in about 20% of individuals older than 70 years of age (Turner
AS, 2001). Women who develop a vertebral fracture are at substantial risk for additional
fracture in the future (Klotzbuecher eM et aI., 2000; Melton LG et aI., 1999). For
example, about 20% of postmenopausal women with a vertebral fracture will develop a
new vertebral fracture of bone in the following year (Lindsay R et aI., 2001). The most
serious osteoporotic fracture is that of the hip. The risk for fractures of the femoral neck
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increases 13-fold from ages 60 to 80 (De Laet CE et al., 1997). Long term nursing home
care is needed for up to 30% of patients (NIH report, 2001). Twenty-five percent of
patients 50-year-old and older die within 1 year after a hip fracture (US Congress OoTA,
1994). The National Osteoporosis Foundation (1996) estimates that one in two women
and one in eight men are at risk of suffering osteoporosis-related fractures during their
lifetime. Furthermore, osteoporotic bone heals

~30%

more slowly than normal bone (Lill

CA et al., 2002).
Health care expenditures attributable to osteoporotic fractures in 1995 were
estimated at $13.8 billion in the United States (Ray NF et al., 1997). Within 50 years the
cost of hip fracture alone in the United States may exceed $240 billion (Lindsay R,
1995). Because elderly people are the fastest growing population in the world and, as
people age, bone mass declines and the risk of fractures increases (Cummings SR et al.,
2002), osteoporosis has become a growing health threat with rising social and economic
consequences. Because bone strength is the ultimate measure of bone quality and none
destructive methods (imaging) are indirect measures of the bone quality, the
understanding of the relationship between bone mechanical strength and bone structural
quality is important for the diagnosis of osteoporosis and the evaluation of osteoporosis
treatment.
The objective of this dissertation project is to develop new methods for the
controlled evaluation of bone quality during experiments designed to test the efficacy of
various treatments for osteoporosis using animal models. This dissertation includes both
mechanical testing and high resolution imaging. Because bone strength is the ultimate
measure of bone quality and none destructive methods (imaging) are indirect measures of

5

the bone quality, the understanding of the relationship between bone mechanical strength
and bone structural quality is important for the diagnosis of osteoporosis and the
evaluation of osteoporosis treatment.

,f

"
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CHAPTER 2. BACKGROUND AND SIGNIFICANCE

2.1

ANIMAL MODEL
Osteoporosis is a slowly progressive disease, necessitating a study of several

years' duration to allow for a response to therapy (Turner AS, 2001). The high cost and
the long time frame of clinical testing makes it reasonable to use animals before initiating
a clinical trial in a post-menopausal osteoporosis study. Laboratory animals can provide
useful information for the understanding of the pathogenesis of the osteoporosis, the
extensive testing of potential therapies and evaluation of prosthetic devices in
osteoporotic bone.
An appropriate animal model for any research should meet the following criteria:

"1) appropriateness as an analog, 2) transferability of information, 3) genetic uniformity
of organisms where applicable, 4) background knowledge of biological properties, 5) cost
and availability, 6) generalizability of the results, 7) ease and adaptability to experimental
manipulation, 8) ecological considerations, and 9) ethical and societal implications"
(Davidson MK et aI., 1987). Unfortunately, it is hard to meet all criteria for osteoporosis
studies, in part because fracture risk has not been reproduced in animals, and it has
proven difficult to ascertain the true degree of correspondence between the mechanisms
which lead to the bone changes in the animal model and its human counterpart (Turner
RT et aI., 2001). Although no single animal model can precisely replicate a human
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condition of osteoporosis, even a model with a small representation of human functions
may be of use for some aspect of the human condition under examination (Hazzard DG et
aI., 1992).
The pathogenesis of osteoporosis has been investigated based on various animal
models, such as dogs (Kimmel DB, 1991; Harvey EJ et aI., 1999; Monier-Gaugere M-C
et aI., 1996; Boyce RW et aI., 1990), rats and mice (Li XJ et aI., 1991; Faugere MC et aI,
1986; Peng Z et aI., 1994; Peng Z-Q et aI., 1997; Baldock PAJ et aI., 1998 ), rabbits
(Gilsanz Vet aI., 1988; Grarde1 Bet aI., 1994), pigs (Maier GW et aI., 1997; Lafage H-M
et aI, 1995; Borah Bet aI., 2000), sheep (Lill CA et aI., 2002; ) and primates (Turner CH
et aI., 1999; Binkley Net aI., 1998; Ba1ena R et aI., 1993).
The ovariectomized rat is an established model of osteopenia and osteoporosis (Li
XJ et aI., 1991; Wronski TJ et aI., 1991; Frost HM et aI., 1992), because skeletal loss
after estrogen deprivation closely parallels the early rapid phase of bone loss
characteristic of postmenopausal humans (Clifford JR, 2004). These include increased
bone turnover, unequal bone resorption and formation, a greater loss of trabecular than
cortical bone, and a rapid initial phase of bone loss followed by a slower phase (Ka1u DN,
1991). With the fast generation time, rodents are often a starting point for preliminary
screenings, efficacy and toxicity of new pharmacological agents or therapeutic modality,
followed by verification in other species, before undertaking clinical trials in human
patients (Aerssens et aI., 1998). Rodents are also inexpensive and easy to house, which
makes them the widely used animal model for osteoporosis studies.
Ovariactomy results in rapid loss of cancellous bone mass in some specific bone
sites. From previous studies it is well known that the degree of osteoporosis is best
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detennined at the metaphyseal femur or tibia of the rat (Wronski TJ et aI., 1985). For
example, the earliest statistically significant time of cancellous bone loss in the proximal
tibial metaphyisis occurs at 14 days and slowing down at 90 days (Wronski TJ et aI.,
1988; Wronski TJ et aI., 1989).

2.2

DRUG TREATMENTS TO OSTEOPOROSIS
There are three kinds of drug therapies to osteoporosis: antiresorptive therapy,

anabolic therapy and combination therapy.

2.2.1

Antiresorptive therapy
Osteoporosis is the consequence of bone loss due to an imbalance in bone

remodeling such that bone resorption exceeds bone fonnation. Because lost bone
structure cannot be replaced, osteoporosis is currently managed with a range of
antiresorptive therapies (Reid, 1999), which prevent further bone loss. Antiresorptive
agents include bisphosphonates, calcitonin, Selective Estrogen Receptor Modulator
(SERM), and estrogen.

Bisphosphonates are synthetic versions of pyrophosphate, a salt that human body
manufactures to help with energy metabolism. Bisphosphonates are similar enough to
bind strongly to existing bone and become embedded in the skeleton. They prevent
further bone loss and create a "protective layer" that slows down osteoclast activity from
dissolving tissue on the bone's surface. This can prevent the development of osteoporosis.
If osteoporosis already has developed, slowing the rate of bone loss reduces the risk of
9

broken bones. Alendronate is the nitrogen-containing bisphosphonate. The action of
alendronate in inhibiting bone resorption has been shown in large clinical trials with
postmenopausal oseoporotic women with and without prevalent fractures (Black et aI,
1996; Hosking et aI, 1998; Li et aI, 1997; McClung et aI, 1998; Pols et aI, 1999).
Alendronate also increases degree and uniformity of mineralization in cancellous bone
and decreases the porosity in cortical bone of osteoporotic women (Roschger et aI, 2001).

Calcitonin is another medication used to decrease bone loss. It is a naturally
occurring hormone, which helps regulate calcium levels in human body and is involved
in the process of bone building. Calcitonin is used in women with osteoporosis to reduce
bone loss. In Bruyere's study (2003), it shows that calcitonin reduces spinal bone
(vertebrae) fractures when taken by postmenopausal women for at least 1 year. But
calcitonin does not appear to be as effective as other medicines, such as alendronate, at
building bone mass and reducing the risk of fractures (Abramowicz et aI, 2002).

Selective Estrogen Receptor Modulators (SERMs) are "designer" drugs that
activate the estrogen receptors, but have different effects on different tissues. In other
words, SERMs select specific estrogen receptors in the body and either stimulate or
depress an estrogen-like response. They increase bone mass, decrease the risk of spine
fractures and lower the risk of breast cancer. One of SERMs, raloxifene, provides
promising benefits for women with osteoporosis. Ettinger et al (1999) reported that
raloxifene increased bone mineral density by 2%-3% and reduced the incidence of new
vertebral fractures by 30% and 50% (in women with and without prevalent vertebral
fractures, respectively) compared to placebo.
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Hormone replacement therapy (HRT) is a means of continuing to provide
estrogen (the female sex hormone) after its production by the ovaries has started to fail at
the menopause. When estrogen levels fall therefore, the bones become thin or brittle with
the result that fractures are more likely to occur. HRT is therefore used to maintain bone
density and thereby reduce the risk of fractures in post-menopausal women or younger
women without ovaries.

Although antiresorptive drugs slow the bone loss and decrease the risk of
osteoporotic fractures by inhibiting osteoclast-mediated bone resorption, they cannot
rebuild bone. In fact, because resorption and reformation occur naturally as a continuous
process, blocking resorption may eventually also reduce bone formation.

2.2.2

Anabolic therapy
In anabolic therapy, both bone resorption and bone formation are stimulated.

Anabolic therapy results in activation of remodeling units that leads to enhancement in
bone formation over bone resorption. The primary anabolic agent is parathyroid hormone
(PTH), which is administered as subcutaneous injections. There are various forms of
PTH. In 2002 the FDA approved recombinant PTH 1-34, with a chemical name of
teriparatide. A large multinational study of women with osteoporosis showed that
treatment with teriparatide increased spinal and femoral neck bone mineral density and
total body bone mineral content, and reduced the risk of vertebral and nonvertebral
osteoporotic fractures by 65% and 53%, respectively (Neer et aI, 2001). Moreover, what
is most intriguing is that teriparatide administration leads to improvement in skeletal
micro architecture in both animals (Turner CH et aI, 1999) and humans (Dempster DW et
11

aI, 2001). Marcus (2003) showed that the skeletal response to teriparatide is largely
independent of age, initial bone mineral density, and prevalent vertebral fractures in
postmenopausal women with osteoporosis.
Fluoride is another bone-building agent. Its side effects were: gastrointestinal
disturbances (34%), gastric ulcers (4.4%), stress fractures (6.9%), very common
arthralgies (34%), and sometimes overdo sages (fluorosis) (Franke J, 1988). It has also
been shown to only improve bone density, but not strength. It is not commonly used
because of these limitations.

2.2.3

Combination therapy
It is tempting to consider the possibility that combination therapy with different

drugs, either through additive effects on suppression of bone turnover or through other as
yet unknown mechanisms, might provide benefits over and above what could be achieved
with either one alone. There have been and will be more clinical trials to test this
hypothesis.
Johnell et ai. (2002) reported on their study of combination therapy with
alendronate and raloxifene in postmenopausal women with osteoporosis. The results of
this well-designed clinical trial indicated that the combined use of these two drugs was
associated with increased bone density and lower bone turnover markers than one can
achieve with either drug alone. Rittmaster RS et al. (2000) have. reported that
postmenopausal osteoporotic women, who have been treated with alendronate given
sequentially for 1 year after intact PTH therapy, responded with an overall increase of
14.6% at the spine together with significant increments in the femoral neck and total
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body calcium. However, the study of Black et al. (2003) showed that the combination of
PTH and alendronate blunted the anabolic effect ofPTH on spine BMD.
Combination therapy is used on most chronic diseases. For osteoporosis, further
studies are needed to determine the proper drug combination and the optimal therapeutic
window.

2.3

EVALUATION OF BONE QUALITY BY IMAGING METHOD
Dual-energy X-ray Absorptiometry (DXA) is considered the clinical gold

standard for measuring bone quality, and quantitative measures of bone mass (bone
mineral content (BMC)) can be derived directly at all sites of interest (Genant HK et aI.,
1996). In World Health Organization (WHO) Technical report series 843 (year 1994),
bone mineral density was used to define osteoporosis because the reduction of bone mass
appears in most osteoporotic changes. Approximately 55% of the variability of femoral
bone strength in side impact and vertical loading are explained by site-specific (femoral)
DXA, with no other technique being able to reach a similar degree of prediction
(Lochrnuller EM et aI., 2003). The disadvantage of the DXA is, however, that DXA
provides 2D projection images, which cannot detect the details of the bone structure
except projection area and length.
Although bone mineral density is used conventionally to diagnose osteoporosis,
the quality of bone, such as bone structure and bone material quality etc, also plays an
important role in the bone strength. It is easily explained from a mechanical perspective
that the strength of a structure is determined not only by the amount and the quality of the
material, but also by the spatial arrangement of the material. Geometrical measures such
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as bone size, cross-sectional area or area moment of inertia have frequently shown to
predict up to 70-80% of whole bone strength (Augat P et aI., 2006). This explains why
older women, with worse bone quality, have a much higher fracture rate than younger
women with the same bone density (Heaney RP et aI., 1998). Thus, detailed analysis of
both trabecular and cortical bone is necessary (Peng Z-Q et aI., 1997).
There are two ways to measure three-dimensional (3D) architecture of bone. One
IS

a destructive way, such as serial milling, which uses PC-based image processing

system and a digital camera to record digitized image of the cut surface (Odgaard A et aI.,
1989). The other is a nondestructive way, such as X-ray computed tomography (CT) and
magnetic resonance imaging (MRI), which can generate a three-dimensional image of
internal anatomy from a large series of two-dimensional images. It is clear that the
nondestructive method is superior to the destructive one. The nondestructive method
allows the specimen to be used for other measurements, such as analysis in different
planes which is very desirable because the anisotropic nature of cancellous bone or the
further mechanical testing which can reveal the relationship between the structural and
the mechanical characteristics. When used in vivo, the real 3D images make it possible to
catch the bone structural changes during the osteoporotic process, and also make it
possible to study cortical bone and cancellous bone separately. Many structural
parameters have been proposed in previous papers, such as trabecular thickness,
trabecular spacing, trabecular number, bone surface, and structure model index (SMI).
More studies need to be done to create a full understanding of relationships between these
parameters and bone competence and fracture resistance.
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2.4

CT SCANNING

2.4.1

Illustration of CT scanning
In 1895, a new radiant energy that was named as X-ray was observed and

recorded by Wilhelm Conrad Rontgen. X-ray can be used to examine internal organs
nondestructively and create two-dimensional images. Godfrey Hounsfield and Allan
Cormack invented computed tomography (CT) in 1972 and made it possible to combine
x-ray images with a computer to provide information about the tissue density across the
cross-section of the tissue, which facilitates quantitative 3D architectural analysis. With
continuing improvements in CT equipment and computer technology, CT became widely
available by about 1980. There are now about 6,000 CT scanners installed in the U.S. and
about 30,000 installed worldwide (http://www.imaginis.com/ct-scanihistory.asp) (Figure
2-1).

A peripheral quantitative computed tomography (pQCT) scanner has been
designed to examine peripheral bones such as the radius or the tibia (Kohlbrenner A et
aI., 1997) (Figure 2-1 b). Because of the relatively lower resolution

(~150 II

m) the

individual trabeculae is not easy to be recognized by the system. The pQCT is available
for research scans only. It is not available yet for clinical purposes as there is no pediatric
reference database (normal range) available for interpretation.
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Figure (b) pQCT

Figure (a) Abdominal and Pelvic CT

Figure 2-1 CT equipment examples

Micro CT was first illustrated by Feldkamp et aI. (Feldkamp LA et aI., 1989;
Kuhn JL et aI., 1990). The system created a 3D object with image resolution of 50 J.lm by
using a microfocus X-ray tube as a source, and image intensifier as a 3D detector, and a
cone-beam reconstruction. Instead of rotating the X-ray source and detectors during data
collection as in clinical CT, the specimen is rotated at various angles. The spatial
resolution of

~ 60

J.lm clearly visualized individual trabeculae of human, allowing a

three-dimensional analysis of trabecular network (Genant HK et aI., 2006). However, the
resolution that appears suitable to human trabecular network is not good enough to the
small animal model, such as rat, where the trabecular widths average about 50 J.lm and
trabecular separations average 150 J.lm or less (Kinney JH et aI., 1995). Another in vitro
micro-CT scanner has been developed (Rueggsegger Pet aI., 1995; Rueggsegger Pet aI.,
1996). They scanned a volume of interest that was of 4x4x4 mm3 and represented in

14x 14x 14 J.lm 3 voxels. The true resolution was a function of detector size, reconstruction
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algorithm, number of projection, etc. The true resolution of the CT scanner used in the
research was not clear.
Higher resolution is generally achieved with synchrotron I1CT and can assess
additional features. For example, synchrotron !lCT was used to image trabecular surface
with the 1.4 11m voxel size. An image of this resolution was able to show a cavity inside a
large trabecular strut (Peyrin F et aI., 1998).
Pixel or voxel dimensions may result in a "pseudo" -resolution that typically
overestimates the physically "correct" resolution by a factor of 2-4 (Jiang Y et aI., 2005).
Therefore, to image individual trabeculae in the rat model in which the trabecular widths
average about 50 11m, the "correct" resolution must be at least 50 11m, requiring
pixel/voxel size of 25 11m or smaller according to Nyquist's theorem (Engelke K et aI.,
1998). Peyrin's work showed that a voxel size of 14 11m is sufficient for most
morhphmetric parameters (Peyrin F et aI., 1998).
The micro-CT is customized to scan small animal models with a nominal
resolution of 14 11m. Similar resolution has been used in other studies, such as 13 11m in
McNamara's study (McNamara LM et aI., 2006) and 15 11m in Boyd's study (Boyd SK et
aI., 2006). The CT equipment (ACTIS 150/225 system, BIR Inc., Lincolnshire, IL) that
was used in this study contains a Fein Focus 225kV microfocus x-ray system (x-ray
source), a custom part manipulator and 150 mm x-ray image intensifier with DALSA lk
x lk cooled CDD camera (x-ray detector) (Figure 2-2). The animal is fixed on the part
manipulator and rotated with the part manipulator when scanning is performed. The Xray source-detector system is fixed at all times.
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Figure 2-2 It is the brief description of how the customized micro-CT system works. The
animal is fixed on part manipulator and rotated with part manipulator when scanning is
performed. X-ray source-detector system is fixed all the time.

2.5

IMAGE SEGMENTATION
Segmentation methods are important to the image interpretation. There are two

different segmentations: bone/non-bone segmentation and cancellous bone segmentation.
Bone/non-bone segmentation is a process to separate bone from soft tissue and the
background. The CT image is composed of pixels with different gray values. The gray
values of the pixels that represent bone are greater than that of the pixels that represent
soft tissues and the background. The bone pixels are brighter than the soft tissue and
background pixels. The analysis of bone structural parameters, such as bone volume,
trabecular thickness, and structure model index (SMI), is based on the binary image that
is converted from the original CT image by bone/non-bone segmentation.
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The most widely used bone/non-bone segmentation method is based on a global
threshold. A single threshold is determined according to the histogram of absolute gray
values of all pixels in a single CT image slice or in the whole image stack. A pixel is set
as bone (white) if its gray value is greater than global threshold, otherwise it is set as
nonbone (black).
In many cases global threshold method does not work well because of the effect

of beam hardening (since lower energy X-rays are preferentially absorbed as the X-rays
traverse the specimen, the center of the specimen is exposed to more high energy X-rays,
which results in darker pixels in the center) and partial volume effects (the gray value of a
pixel with both bone material and nonbone material is lower than that of a pixel with all
nonbone material, and greater than that of a pixel with all bone material). Local threshold
method leads to more precise segmentation result by choosing specific threshold to each
pixel according to the information provided by its neighborhood of a selectable size.
Waarsing JH et al. (2004) developed a local threshold algorithm by detecting edges of the
bone. The gray value of a voxel that is part of the edge sets is used as a local threshold for
its neighbors.
Cancellous bone segmentation is used to segment cancellous bone from cortical
bone, so the cancellous bone and the cortical bone can be analyzed separately. Due to the
complexity of cancellous bone network and a large number of image slices, it is a timeconsuming and tedious process to do segmentation manually. It is also difficult to tell
where the exact boundary between cancellous bone and cortical bone is if the cortex is
very porous because of osteoporosis or other diseases, or if the volume of the interest
(ROI) is dominated by cancellous bone. Manual segmentation of images often produces
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subjective results that are highly dependent on the knowledge and experience of the
operator. Therefore, more efforts have been made recently to do segmentation
automatically (Dufresne T, 1998; Helterbrand JD et aI., 1997; E1moutaouskkil A et aI.,
2002). Since automatic segmentation by computer is a more objective and reproducible
process, it allows longitudinal study of the same subject and comparison studies between
different subjects with reduced human bias and error. He1terbrand et al (Helterbrand JD et
aI., 1997) has developed an automatic segmentation method based on the knowledge that
generally cortical bone elements are closer to the outer bone surface and have higher
intensity than cancellous bone elements. The accuracy of this method decreases when the
cortical bone thickness varies a lot in a single image slice. Dufresne (Dufresne T, 1998)
proposed Euclidean Distance Map (EDM) in which each voxel of 3D whole bone data set
contains its distance information to the nearest surface. The cortical bone is determined
by finding the center of the cortical bone and dilating out the center based on its EDM
value. This method requires that the holes in cortex are removed before segmentation is
carried out, again resulting in a slow manual process and some human errors. Another
approach involves use of a dual threshold technique (Buie HR et aI, 2007), in which one
threshold is used to extract the non-bone region and the other threshold is used to define
the marrow cavities. To apply the algorithm, the user must adjust two threshold values to
the specific dataset at hand, which impact the final segmentation result. Dilation and
erosion operations are then used to reconnect marrow cavities, thus eliminating
trabeculae, allowing extraction of a trabecular region mask via a connectivity filter. The
extent of the dilation should be as small as possible while satisfying the requirement: the
cortical porosity is removed and marrow cavities are reconnected for all datasets.

20

Unfortunately, this requirement cannot be satisfied for all cases, which leads to bad
decision of the pores in the cortex, which further leads to bad cancellous bone
segmentation.
In this dissertation, an automatic segmentation method based on the binary image

information of bone structure only is introduced. Similar with the method of Buie et al
(2007), marrow space is used in the new method to define the cancellous bone. In order
to find the marrow space, instead of dilation and erosion operation in Buie's method, the
new method takes advantage of 3D structure of the non-bone region, which can define
the pores in the cortex objectively and precisely. Though the experience of two years
using this method has shown excellent qualitative agreement with manual techniques, the
new method was also measured quantitatively. The method was validated by comparing
segmented results with manual work and a published method, the Helterbrand method.
The principle advantages of the new method are as follows: 1. It is automatic,
precise and accurate; 2. The cancellous bone segmentation is dependent on the bone
architecture only, no assumption is needed; 3. The method has the potential to do
segmentation even when the ROI has a complex structure and irregular shape; 4. Any
pores in the cortex can be distinguished from the marrow space objectively and
accurately. The method is validated by comparing segmented data sets with manual
method and a previous published segmentation method (Helterbrand method).

2.6

EVALUATION OF BONE COMPETENCE BY MECHANICAL TESTING
Mechanical tests in the form of three-point bending, four-point bending and

torsion are the most common methods of measuring bone mechanical properties (Turner
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RT et aI., 2001). Because these testing are performed at the middle shaft of the diaphysis,
they measure cortical bone qualities. Since the bone size of the rat is so small, there have
been no reports to my knowledge of attempts to study rat bones using four-point bending
testing due to the small size of rat bone sample. Three-point bending is a simple testing
due to the easy bone sample preparation and test execution. It is suitable for long bones
because the span of the specimen that is loaded must be sufficiently long to guarantee an
accurate test. Three-point bending test has been applied to measure the strength of
cortical bone (Azuma Yet aI., 1998; Yang KH et aI, 2007; Trebacz H et aI, 2006). As an
alternative to bending tests, torsional testing can be used for the evaluation of bone
mechanical qualities (Lind PM et aI., 2001; Burstein AH et aI., 1971; Lepola V et aI.,
1993). Torsion testing applies the load at the end of the bone sample, which allows the
load away from the region of the interest (ROI). Torsional testing requires the mounting
of the specimen ends into the testing grips, which increases the time, labor and the cost of
testing.
Assessment of trabecular structural characteristics and mechanical qualities may
further improve the ability to understand the pathophysiology and progression of
osteoporosis and other bone disorders. Compression testing has been performed on
trabecular samples which have been machined into cubic subvolumes (Ulrich D et aI.,
1997). Unfortunately, the rat model is small and its cancellous bone cores do not meet the
continuum requirement for compressive tests (Harrigan TP et aI., 1988) that the
specimens side length span at least five intertrabecular distances. Indentation test is a type
of compression test where an indentor is driven into a sectional surface of a bone
specimen (An YH et aI, 1997). Although the failure mechanisms are more complicated
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and less clear than the conventional compression test, indentation testing has been used to
measure the biomechanical properties of cancellous bones, such as Young's modulus and
strength of cancellous bone (Sumner DR et aI., 1994; Aitken GK et aI., 1985; Katoh T et
aI., 1996; An YH et aI., 1997; Jamsa T et aI., 2002; Khodadadyan-Klostermann C et aI.,
2004; Hvid I et aI., 1985). The indentation testing is very sensitive to the position of the
exposed cancellous bone surface. Since it is not easy to get the same exposed cancellous
bone surface of different bone samples, previous studies has focused on mapping
biomechanical properties of a single bone specimen, instead of comparison between
different specimens. In Pradama Study, the new indentation testing method has been
developed to evaluate the strength of cancellous bone resulted from different drug
treatments of osteoporosis.
The complete understanding of whole bone performance is very useful for the
deep understanding of the pathogenesis of the osteoporosis and the evaluation of drug
treatments. The mechanical properties of entire bone can be measured by compression
testing of vertebrae (Fox J et aI., 2006) and cantilever testing of the neck of the femur
(Azuma Y et aI., 1998; Sogaard CH et aI., 1994). These tests more closely approximate
the type of failures associated with osteoporotic fractures. A standardized bending and
breaking test at the metaphyseal region of tibias of the rat has been developed recently.
This three-point breaking test is highly sensitive to evaluate hormones, substances, and
even medications with regard to their osteoprotective efficiency, because the osteoporotic
fracture plays the key role in osteoporosis (Sturmer EK et aI., 2005).
There are other testings to measure bone quality. For example, tensile testing can
be applied on cortical bone and/or cancellous bone, which requires that the bone
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specimen must be big enough to meet the continuum limitation; Microtensile testing is
carried out on individual trabeculae (McNamara LM et aI., 2006) to assess the
mechanical behavior of trabecular bone tissue.
Mechanical testing can give direct results of bone strength, but it cannot be used
clinically because it is destructive. A better understanding between image analysis and
mechanical testing is very helpful clinically because nondestructive methods are the only
way to check patients and bone competence is the objective of the clinical examination

2.7

RESEARCH TASK
The main purpose of the present study is to evaluate bone quality using image

analyses and mechanical test methods. The main objective and the general aim of the
study are to: 1) isolate as much cancellous bone as possible to study the drug effect on the
rat model, especially for in vivo study, 2) develop a novel, automatic, more precise, and
more objective cancellous bone image segmentation method, 3) develop a more precise
mechanical indentation test to evaluate cancellous bone quality, 4) develop more
sensitive methods (compared to more traditional method, such as Archimedes density
measurements and three-point bending testing) to show the differences of the bone
structure caused by OVX or different drug treatments, 5) Develop a method to evaluate
cortex maximum tensile stress based on the information from CT scanning image, and 6)
Relate the 3D image analysis to the bone quality from mechanical results and drug
treatments.
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CHAPTER 3. MATERIAL AND METHODS

3.1

GENERAL DESCRIPTION
All of the methods developed and described in this dissertation were applied to

evaluate the bones of rats used in collaboration with Dr. William Pierce. A total of four
separate experiences were performed to study various new drugs being developed by his
group for the treatment of osteoporosis. The new drugs are not the focus of this
dissertation, so those data are not used. The data from control animals and those treated
with reference drugs are presented. The first experiment is referred to as the Alendronate
Study simply because of the large response observed in the alendronate treated rats in that
experiment. The remaining three experiments are referred to as Pradama Experiment 1,
Pradama Experiment 2, and Pradama Experiment 3.
The structural analysis was an image analysis based on the information that was
provided by CT scanning images. In vivo image analysis was used in the Alendronate
Study. Ex vivo image analysis was used in the Pradama Studies. Table 3-1 describes the
structural analysis used in this study.
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Structural analysis
Studies
Scanning procedure
Study objects
Bone/non-bone
segmentation method
Cancellous bone
segmentation method
Improvement

I . descnptIon
Tabl e 3-1 Structura analysIs
In vivo
Ex vivo
Alendronate study
Exp 1, Exp 2 and Exp 3
One rat per scanning
Six bones per scanning
Proximal metaphysis of Proximal metaphysis of right
right tibia
tibia
Global threshold Method
Global threshold method in
Exp 1; Local global threshold
method in Exp2, Exp3
Helterbrand method that is New method that is described
described in 3.3.4
in 3.4
1. Isolate as much cancellous bone as possible to study the
drug effect on the rat model
2. Developed a GUI
2. The new method used for
program by MatIab to
cancellous bone
separate VOl from other
segmentation is totally
bones that are connected
automatic, more precise and
more objective
to VOl

There were no mechanical tests in the Alendronate Study. Mechanical tests were
executed in the Pradama Studies. Table 3-2 describes the mechanical tests used in this
study.

Mechanical
tests
Studies

Table 3-2 Mechanical test description
Torsion
Three point
Indentation
bending
Pradama Exp 1,
Pradama
Pradama Exp 1,
Expl
Exp 2 and Exp 3
Exp 2 and Exp 3

Scanning
procedure

Study objects

Improvement

Six bones per
scannmg

Left femur

One bone
(embedded in
Bondo) per
scannmg
Proximal
Middle shaft of
metaphysis of left
right femur
tibia
Develop a new
Make it possible
to evaluate cortex method to trim the
maximum tensile top of the bone
stress based on
sample at a precise
position to expose
the information
from CT scanning the cancellous bone
Image
surface

Three point
breaking
PradamaExp
1, Exp 2 and
Exp 3
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Proximal
metaphysis of
Right tibia

3.2

STUDY OBJECTS AND DRUG TREATMENTS
The animal-use protocol in the research was approved by the institutional animal

care and use committee at the University of Louisville. All rats were overiectomized
(OVX) at the beginning of the experiment except the rats of the Sham group. Sham
operations were performed on the Sham group by exposing the ovaries and then closing
the incision. Sham procedures are typically performed to isolate the actual surgical
intervention as an independent variable. In the Alendronate Study, the rat group name
was arranged as TreatmentMethod. For example, SHAM means that all rats of this group
were sham-operated. In pradama studies, the rat group name was arranged as
TreatmentMethod_SacrificedTime. For example, SHAM_W6 means that all rats of this
group were sham-operated and were sacrificed six weeks after surgery; OVX_W5 means
all rats of this group were ovariectomized and sacrificed five weeks after surgery;
ALEN_W12 means that all rats of this group were ovariectomized then treated by
alendronate and were sacrificed twelve weeks after surgery.

3.2.1

Alendronate study
Twenty-four female Sprague-Dawley rats weighing 150g, corresponding to about

7-8 weeks old, were purchased at the beginning of the experiment, in which four rats
were sham-operated and thirty rats were ovariectomized by the vendor. All rats were
housed in plastic cages (L 430 mm x W 220 mm x H 200 mm), one rat per cage, and
subjected to a 12-hour light/dark cycle. All rats were allowed to move freely throughout
the experiment period. Tap water and the standard rodent diet were available to all rats ad
libitum.
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There were 6 groups of rats based on treatment: sham control (SHAM), OVX
control (OVX), OVX + Alendronate (ALEN), OVX + 17

~-EstradioI2

(E2), OVX +

Raloxifene (RALOX), and OVX + Teriparatide (PTH) (Table 3-3). At the beginning of
the eighth week after surgery, each rat was weighed and injected subcutaneously three
times per week (on Monday, Wednesday, and Friday). On the sixteenth week after
surgery, the rats were sacrificed using CO2 • The uteri, blood, femur, tails and tibiae were
collected and refrigerated. 10% buffered formalin was used to fix the femur, tails and
tibiae.
Table 3-3 Treatment Arrangement fior Alendronat e Studly
r:F.J
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Pradama study
All rats (totally 120 rats) were housed in plastic cages (L 430 mm x W 220 mm x

H 200 mm), three or four rats per cage, and subjected to a 12-hour light/dark cycle. All
rats were allowed to move freely throughout the experiment period. Tap water and the
standard rodent diet were available to all rats ad libitum. The rats were asphyxiated using
CO2 • The uteri, blood, femur, vertebrae and tibiae were collected. Right femur, left
femur, right tibia and left tibia were soaked in saline and frozen immediately after the
collection. Vertebrae were soaked in formalin and refrigerated for further study.
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3.2.2.1 Pradama study: Experiment 1 (Pradama Exp1)
Thirty-seven female Sprague-Dawley rats, about six-months old, were purchased
at the beginning of the experiment, in which eleven rats were sham-operated and twenty
rats were ovariectomized by the vendor. There were ten groups of rats based on treatment
and the time point of sacrifice (the week of the surgery was set to week zero): sham
control (SHAM_W2), sham control (SHAM_W4), sham control (SHAM_W8), OVX
control (OVX- W2), OVX control (OVX- W4), OVX control (OVX- W8), OVX +
Alendronate (ALEN_W8), OVX + Estradiol (E_W8), OVX + 17-Ethinyl Estradiol
(E2_W8), and OVX + Teriparatide (PTH_W8) (Table 3-4). All rats were weighed on the
fifth day after surgery. On the thirty forth day after surgery, drugs were given to rats three
times per week (on Monday, Wednesday, and Friday). PTH and Estradiol were injected
subcutaneously. 17-Ethinyl estradiol and alendronate were given orally.
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3.2.2.2 Pradama study: Experiment 2 (Pradama Exp2)
Forty-one female Sprague-Dawley rats, 5.5 month old, were purchased at the
beginning of the experiment, in which ten rats were sham-operated and thirty-one rats
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were ovariectomized by the vendor. There were seven groups of rats based on treatment
and the time point of sacrifice: sham control (SHAM_ W5), sham control (SHAM_ WI I ),
OVX

control

(OVX_ W5),

OVX

control

(OVX_ WI 1),

OVX

+ Alendronate

(ALEN_Wll), OVX + 17-Ethinyl Estradiol (E2_Wll), and OVX + Teriparatide
(PTH_Wll) (Table 3-5). All rats were weighed on the sixth date after surgery. On the
forty second day after surgery, drugs were given to rats three times per week (on
Monday, Wednesday, and Friday). PTH was injected subcutaneously. I7-Ethinyl
estradiol and alendronate were given orally.

T abl e 3-5 Treat mentArrangement£or Pradama Exp 2
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3.2.2.3 Pradama study: Experiment 3 (Prodama Exp 3)
Forty-two female Sprague-Dawley rats, 6 month old, were purchased at the
beginning of the experiment, in which eleven rats were sham-operated and thirty-one rats
were ovariectomized by the vendor. There were six groups of rats based on treatment and
the time point of sacrifice: sham control (SHAM_W6), sham control (SHAM_WI2),
OVX

control

(OVX_W6),

OVX

control

(OVX_WI2),

OVX

+ Alendronate

(ALEN_W12), OVX + 17-Ethinyl Estradiol (E2_W12), and OVX + Teriparatide
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(PTH_W12) (Table 3-6). All rats were weighed on the fourth date after surgery. On the
forty-fifth day after surgery, drugs were given to rats three times per week (on Monday,
Wednesday, and Friday). PTH was injected subcutaneously. 17-Ethinyl estradiol and
alendronate were given orally.
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Sixteen-bit CT image data were collected using a customized micro-CT system
(ACT IS 150/225 system, BIR Inc., Lincolnshire, IL). The study object was the proximal
metaphysis of the right tibia. All the rats were scheduled to be scanned at week 0, week 8,
week 12 and week 16 after sham or ovariectomy surgery. Before the scanning, the rat
was placed in a plastic chamber. The chamber consisted of two acrylic cylinders and a
flange (Figure 3-1). The flange was located on the lower cylinder. The chamber was fixed
on the part manipulator by tightening screwing bolts through the holes in the flange and
the holes in the part manipulator, which made sure that there was no relative movement
between the chamber and the part manipulator. The upper cylinder had 2.75 inch inner
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diameter which should provide enough space for a rat and 3 inch outer diameter. The top
cover had 3 inch inner diameter and there was a swivel fitting on its top side. The swivel
was connected with a tube, through which the gas, lLimin O2 with 2-2.5% isoflurane by
volume, could enter into the chamber for the purpose ofrat's anaesthesia. The lower side
of the upper cylinder was connected with the lower cylinder that had 1.25 inch inside
diameter. A rough hook of VELCRO was fixed on the lower side of the lower cylinder.
The scanning equipment is shown in Figure 3- I.

It is the description of the CT scanning used in the Orthopaedic
Figure 3-1
Bioengineering Lab. X-ray source is on the left, part manipulator is in the middle and xray detector is on the right. X-ray source-detector system is fixed all the time. Before the
scanning, a rat is sedated and fixed on the part manipulator. During the scanning the rat is
rotates with part manipulator.

Generally, the rat was sedated within 5-10 minutes. Because the rat does not blink
when it is under unconscious conditions, ophthalmic ointment (NEO-POLY-BAC,
Bausch & Lomb Incorporated, Tampa, FL) was used to maintain proper moisture of the
eyes. The tail, the right hint leg of the rat and a soft loop of VELCRO were tied together
by tape. The rat was placed in the upper cylinder while the tail and the right hint leg were
extended into the lower cylinder. The tail and the right hint leg were fixed by pressing the
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soft loop surface to the rough hook surface of Velcro, which made sure that there were no
relative movement between the study object (tail and right leg) and the chamber during
CT scanning. By pulling down VELCRO soft loop and pressing soft loop surface to
VELCRO rough hook surface, the right hint leg remained straight and erect during the
scanning. Since the rat cannot support its body in erect position because of its relaxed
muscle when it is sedated, the rat was stretched up in a vertical position by hanging its
teeth on a loop of string.

3.3.2

Image registration
The aim of the registration: after registration, the image stacks of the VOl (the

proximal metaphysis of tibia) of the same rat scanned at four different time points (week
0, week 8, week 12 and week 16) should be in the same orientation and the same
position. An exact biological match of two scans made at different time points would be a
match in which a bone structure present in one scan falls on top of the same bone
structure in the second scan. Because bone grows during the experiment period, the
longer the time period between the two scans, the greater the morphological changes in
the bone. To make the change between the biological matches at two time points as small
as possible, the image stack that was scanned at the middle time point (week 8) of the
whole study was chosen as the reference image stack of registration, and the image stacks
at week 0, week 12 and week 16 (floating image stacks) were oriented to match it, which
resulted in the longest time period between the two time points of a registration to be 8
weeks.
There were four steps to do registration.
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Step 1: Display the four image stacks of the same rat scanned at 4 different time
points.
An original CT image data set that was obtained directly after CT reconstruction

included 749

~

1284 image slices and the size of each image slice was 8196 KB. The

image shown in Figure 3.3-2 (a) was an example of an original CT image. Since the size
of the image stack was very big (6.1

~

10.5 GB), it was hard to display even only one

image stack on the computer screen because of the computer memory limitation. ImageJ
was used to open the image data sets. The following measures were taken to make the
displaying fast and successful: 1) the scale of the image was set to 25%, 2) one image
every four images was read in one image stack, and 3) the original image was converted
to 8-bit grayscale. The required computer memory was decreased dramatically by taking
these measures. For example, the size of an image stack of which the original size was
6.1 GB was reduced to 47 MB (6100 MB / 4 (read one slice every 4 slices) / (4
image scale) / 2 (converted to 8-bit)

=

* 4) (25%

47 MB), which was only 0.78% of the original

size. Although some details of the image data sets were lost by taking these
measurements, the reduced images were still good enough because only rough
registration was performed in this step.
Step 2: Rotated the floating image stacks manually to such position that the VOl
of the floating image stacks had the similar orientation to that of the reference image
stack.
To compare the relative orientations, it was also necessary to display the same
positions of the four image stacks. Because bone is growing, the structure of the bone is
changing. In the analysis, it was assumed that arterial openings in the cortex do not
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change, or at least to a much lesser extent than the general shape of the bone. Figure 3-2
(a) and (b) show the images of a floating image stack before orienting and after orienting,
respectively.

Figure (a)

Figure (b)

Figure (c)

Figure 3-2 It is the orientation process of a floating image stack. Figure (a) shows the
image with cortex opening before orientation. Figure (b) shows the orientation result. The
VOl was cut from original CT image stack by a rectangular (figure (c)).

Figure 3-3 shows the orientation results, in which Cross-section A-A, B-B, C-C
and D-D were the same positions at week 0, week 8, wee 12 and week 16, respectively.
The opening in these cross-sections should be the same artery opening in cortex at
different time points.
Step 3: Choose the volume for registration purpose (VReg) and the volume for
reslicing purpose (VRes).
TO, T8, T12 and T16 in Figure 3-3 were distances between the slices with the
arterial opening in the cortex and the slices that were just below the growth plate at week
0, week8 , week 12 and week 16, respectively. Since bone is growing, TO should be the
minimum value of TO, T8, T12 and T16. The top slice of each image stack for VReg was
at the distance of TO proximally from the slice with the arterial opening in the cortex.
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BO, B8, B12 and B16 in Figure 3-3 were distances between the slices with the
arterial opening in the cortex and the slices that were located at the most bottom of the
image stack at week 0, week8, week 12 and week 16, respectively. The bottom slice of
each image stack for VReg was at the distance of the minimum value ofBO, B8, B12 and
B 16 distally from the slice with the arterial opening in the cortex.
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Figure 3-3 Description of the registration parts and the reslice parts

The top slice of VRes part was chosen to make sure that the whole metaphysis at
the proximal end of the tibia was included. The bottom slice of VRes was the same as
that of VReg.
The VOIRR (Volume of Interest, including both Reslice part (VRes) and
Registration part (VReg)) was cut from the original reconstructed image in rectangular
shape (Figure 3-4). The rectangle should be big enough that the whole VOIRR was
included and also small enough to save computer memory and computing time.
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Figure (a)

Cross-section A - A

Figure (b)

Cross-section B - B

Figure ( c)

Cross-section C - C

Figure (d)

Figure 3-4 The position of the image of the tibia was moved from one side of the
rectangle to another side of the rectangle when the image slices were checked from top of
the tibia to the bottom of the tibia because the tibia was not in the vertical position when
it was scanned.

The following information that was got from observing original image stacks was
used as the input for a in-house Matlab (Mathworks, MA) program to do the rough
registration: the rotation angle that was used to rotate the original reconstructed data sets
to expected orientation, the top and bottom slice number for registration, the top and
bottom slice number for reslice, x and y position of the right upper corner and the left
lower corner of the rectangle that was used to cut the tibia stack from the original
reconstruction image set.
Step 4: Register and reslice image stacks.
After the rough registration, each VReg of the floating image stacks (week 0,
week 12 and week 16) should move a little bit in x, y and z directions, and rotate a little
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bit around x, y and z directions to match the VReg of the reference image stack (week 8)
as well as possible. The information of translation in x, y, and z directions and rotation
around x, y, and z directions for each floating image stack was calculated by an in-house
Matlab program and used as the input for the res1icing process. An in-house res1icing
program created by Matlab was used to reslice the VRes of each floating image. Step 4
was accomplished by the program of Shuo Yang (Yang S, 2006). It took one day to
complete registration and reslice process for one rat. Totally 45 days were needed to
finish registration and reslice process for 45 rats. The image stacks that were created by
registration and reslicing process were used for the image segmentation.

3.3.3

Segmentation of metaphysis from other bones
The study object in the research was the metaphysis of the proximal tibia. The

objective of this step was to remove the epiphysis and/or patella from the image stack, so
there was only metaphysis left for later analysis.
The volume of interest (VOl) for image segmentation was taken from the image
slice that was just below the growth plate of the proximal tibia and progressed distally
approximately 3.75 mm (269 slices x 14 microns/slice). This image stack included the
VOl (metaphysis) and other bones (such as epiphysis and patella) (Figure 3-4 (b), (c) and
(d)). The VOl that was surrounded by the rectangle in Figure 3-4 (b), (c) and (d) might
change a little bit after registration and reslice process, but it gave a good picture about
what kind of trouble will be in the further segmentation process. If the VOl was
connected with other bones, it was difficult to figure which was the VOl automatically by
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computer. It resulted in further troubles when the cancellous bone of the VOl was
separated from the cortical bone of the VOL
Figure 3-5 is a description of how whole bone segmentation worked. An in-house
GUI program created by Matlab is illustrated in Figure 3-5a. Before whole bone
segmentation, two types of the image stack were created: one stack was black-white
image style (Figure 3-5a) in which pixels with black color are non-bone elements and
pixels with white color are bone elements, and the other stack keeps the information of
pixel gray intensity (Figure 3-5b). To create black-white image stack, the global threshold
for non-bone and bone tissue (bone/non-bone threshold) was determined slice by slice
using the method ofOtsu, N. (Otsu, N., 1979), which computed the threshold to minimize
the intraclass variance of the black and white pixels. The pixel represented bone element
if its gray intensity was greater than bone/non-bone threshold, otherwise, it represented
non-bone element.
By selecting 'OpenStackl' button (the left upper button in Figure 3-5a), the image
stack with black-white style was opened and displayed on GUL A polygon mask can be
plotted after selecting 'PlotMetMaskLine' button (the left upper button in Figure 3-5a).
All metaphysis (VOl) should be inside the mask, and other bones should be outside of the
mask. The bone elements that were inside the area of the mask were kept and the bone
elements that were outside of the mask were deleted after the whole bone segmentation
was carried out by selecting 'Segmentation (from bottom to top)' button (the left lowest
button in Figure 3-5a). 'ConfirmMask' button (the left middle button in Figure 3-5a) was
used to record the mask shape, the mask position and the number of the slice on which
the mask was plotted. For example, the number of the current slice is 239 in Figure 3-5. If
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' ConfirmMask' button was clicked, the mask position was recorded and all bone pixels
on the slice 239 that were inside the mask were kept and all bone pixels on slice 239 that
were outside of the mask were deleted after segmentation. It was not necessary to plot
mask for every slice of an image stack because one mask can be valid for several
continuous slices. If no mask information of a slice was recorded by selecting
' ConfirmMask' button, the mask of the nearest slice with the lower slice number relative
to the current slice was used as the mask for the current slice .

. . _:~_J.•..;:_. . :::-_I- ". ." Figure ( a ) A mask is created .
The bone that is inside the mask is metaphysis (VOl)

Fibure (b) An image slice created after
registration and reslicing process

D

Running a program created by Matlab

Figure ( c ) Final result of whole bone segmentation

Figure 3-5 Whole bone segmentation
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Because the black-white image stack illustrated clearly which parts were bone and
which parts were non-bone, which made the boundary clearer between the VOl and other
bones, it was used to create whole bone mask. Then the mask was applied on the image
stack with the information of pixel gray intensity to create the stack which contained the
VOl only (Figure 3-5c).
The same method can be used to separate cancellous bone from cortical bone. It
works if appropriate mask for cancellous bone was plotted and only cancellous bone was
maintained after selecting 'Segmentation' button. But this method is time and labor
consuming. Much more slices need their unique masks because the boundary between
cancellous bone and cortical bone changes a lot when image slices change. The mask for
a certain slice is such more delicate because more details need to be taken care, which
means that much more clicks are needed to create one mask.
An automatic method to segment cancellous bone from cortical bone was

acquired to save time and labor.

3.3.4

Segmentation of cancellous and cortical compartments (Helterbrand method)
The cancellous bone segmentation was carried out by a previously described

method (Helterbrand et aI., 1997) (Figure 3-6).
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An image slice
Figure (a)

Image dilation
Figure (b)

Mask outline
Figure (e)

RingDist
Figure (f)

Image erosion
Figure (c)

Bonelndex
Figure (g)

WholeBoneMask
Figure (d)

Result of segmentation
Figure (h)

Figure 3-6 Helterbrand method was used to segment cancellous bone from cortical bone

There were two reasons that the refining procedure was needed after applying
Helterbrand method: 1) different image slices might have much different shapes of
BoneIndex histogram cloud, especially there were inflexions on the histogram curve,
and/or there were more than one peak between the first peak and the second peak, which
led to bad decision about the value of CortexThresh, and 2) Helterbrand method was
based on the knowledge, even though the intensity information was also included, that
pixels that represented cortical bone were nearer to mask outline and pixels that
represented cancellous bone were located further to mask line. If the thickness of cortex
varied greatly in a single image slice, it was unlikely to find a good value of
CortexThresh for this slice to segment cancellous bone from cortical bone perfectly.
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The Helterbrand method was semi-automatic, requiring several trials to get a
better threshold. Most of time, the manual refining procedure was needed to get good
cancellous bone segmentation results.

3.4

A NOVEL AUTOMATIC METHOD TO SEGMENT CANCELLOUS BONE
FROM CORTICAL BONE
The basic idea of the new method is that a contiguous three-dimensional (3D)

non-bone region that is located inside the ROI can be defined as the marrow region. Any
bone material that is surrounded by the marrow region is considered cancellous bone
while bone that is outside of the marrow region is cortical bone.
The marrow region is defined based on the following criteria: For a 3D ROI, i)
Marrow elements are connected to each other and form one and only one continuous
marrow cavity; ii) All cavities in the cortex are separated from the marrow cavity; iii)
The marrow cavity is the largest cavity among all cavities in ROI.
After 3D marrow region was defined, its 2D image structure was used to create
CancellousMask slice by slice. This 2D marrow region was used to create
CancellousMask by dilating-filling-eroding process. The perfect CancellousMask should
cover and only cover the pixels that represent marrow elements and cancellous bone
elements.

Segmentation algorithm
The following sections describe the algorithm steps in detail:
Step 1: Create 3D cavity model ofROI (Figure 3-7).
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Figure (c) WholeBoneMask (Fill and then
erode figure (b) to original size and shrink
the image slice to original size)
(WholeBoneErodeDilateDiff=O)

Figure (d) Cavities used to create
3D cavity model of WBROI

Figure 3-7 The dilating-filling-eroding process was used to find WholeBoneMask. The
non-bone elements that were covered by WholeBoneMask were treated as cavity
elements and were used to create 3D cavity model.

The cavity elements in ROI were marrow elements and other soft tissue elements
that were enclosed by cortex. The global threshold for bone and non-bone tissue
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(bone/non-bone threshold) was detennined slice by slice using the method of Otsu, N
(Otsu, N, 1979). The pixel was set as bone (white) if its gray value was greater than the
threshold, otherwise it was set as nonbone (black) (Figure 3-7a). WholeBoneMask for a
single image slice was found by dilating-filling-eroding process, which was used to fuse
the cortex openings (Figure 3-7). When the image was dilated, the image slice was
enlarged at the same extent in case that the dilated image flew out of the image slice.
The non-bone elements that were covered by WholeBoneMask were treated as
cavity elements. The gray intensity of non-bone pixels that were covered by
WholeBoneMask was set to 1 and the gray intensity of all other pixels was set to 0
(Figure 3-7d). 3D cavity model of whole bone was a three dimensional numeric array by
overlaying the cavity elements slice by slice.
Step 2: Create 3D marrow model ofROl.
The connected cavity elements re labeled in 3D cavity model of ROI, in which the
value of non-cavity pixels was kept at zero. The connected cavity elements were assigned
as a single cavity. The pixels labeled 1 made up one cavity object, the pixels labeled 2
made up a second cavity object, and so on. The largest cavity object was defined as the
marrow cavity. This method was called as whole matrix method because the largest
object was defined in a whole 3D matrix (Figure 3-9). The intensity of marrow elements
was set to 1 (white) and the intensity of non-marrow elements was set to zero (black) in
3D marrow model.
Step 3: Find CancellousMask.
CancellousMask should cover all pixels (but only cover the pixels) that
represented the marrow elements and the cancellous bone elements. When a single image
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slice of marrow region was concerned, it was noticed that cancellous bone was inside or
between the marrow region and cortical bone was outside of the marrow region (Figure
3-8b). So CancellousMask could be defined by dilating (Figure 3-8c) and filling this
marrow region, then eroding it to its original size (Figure 3-8d) by eroding the dilated
image the same extent as that of dilating. The CancellousMask is shown in green and
blue color in Figure 3-8e. The green region was the overlapping region of the
CancellousMask and the marrow, the blue region was the overlapping region of the
CancellousMask and the bone.

Figure (d) Fill and erode figure (c) to
its original size, and shrink the image
slice to its
size

Figure (e) Cancellous Mask in green and
blue color

Figure (f) Cancellous bone

Figure 3-8 CancellousMask was created by eroding the dilated marrow region to its
original size.
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Step 4: Segment cancellous bone from cortical bone.
The bone pixels that were covered under CancellousMask were treated as
cancellous bone (Figure 3-8f). The bone pixels that were not covered by CancellousMask
were referred as cortical bone. The cavities that were touching cortical bone region and
were not connected to marrow region were referred as cavities in cortex.
Algorithm improvement
1) Efficiency improvement
It worked theoretically to find the largest object by whole matrix method.

However, it was difficult to handle a large 3D matrix (determined by the size of the
image stack). For example, there was an image stack (H * W * SliceN = 505 * 509 *
171). Considering the resolution of the image (for example 0.014mm), 171 slices
represented a ROI with 2.4 mm in axial direction, which was not a big sample. The input
matrix was 44 MB (505*509*171 *1) because it was binary version and the class of the
binary version was 8-bit integer (1 byte per element). Since the total number of separated
objects in the 3D matrix was unknown before calculation, the output matrix with labeled
objects should be of class double, which means 8 bytes per element. The size of the
output matrix was 352 MB (505*509*171 *8). To find the largest object, more than 396
MB (44 MB + 352 MB) memory was needed since the calculation needed other variables
and matrixes. Because of the limitation of the computer memory, the size of the image
stack was limited, that is, the size of the bone sample was limited.
In order to save memory, a method called the overlapping method was developed
to find the largest object for a 3D model. To illustrate it clearly, a 2D matrix was used
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here as an example (Figure 3-9). One row in the 2D matrix represented a single slice in a
3D matrix.
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Figure (a) Input matrix A . The
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colored with yellow color.

Figure (b) The connected
elements were labeled .
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Figure 3-9 Illustration of whole matrix method and overlapping method

To find the largest object, a row was chosen as a start point (reference row). The
largest part (LP) in reference row must be part of the largest object of the whole matrix.
For example, for a matrix shown in Figure 3-9, row 2,3,4, 5, 7, 8 or 10 could be used as
the reference row. The elements with value of 1 that were connected to LP were
considered as the elements of the largest object of the whole matrix while considering
only two rows at a time and moving in two directions through the matrix (Figure 3-9d).
One cycle was completed by carrying out the same process from the last row to the first

48

row (Figure 3-ge), and then from the first slice to the last slice (Figure 3-9f). The whole
largest object was identified by continuing the cycling till the result were the same as that

from the previous cycle.
2) Accuracy improvement: False marrow
The contour of WholeBoneMask was not the same as that of the original image
because the region growing process smoothed the image edges. Some background pixels
that were located along the outer surface of the cortex were treated as cavities (Figure
3-7f). These elements were called as false cavity elements. False cavity elements that
were not connected to marrow cavity form false cavities, which had no effect on
segmentation result. False cavity elements that were connected to the marrow cavity form
false marrow, which resulted in errors in segmentation result (some cortex elements were
treated as cancellous bone elements).
The region growing process was used to erase the cortex openings. If there were
no openings on the cortex, the WholeBoneMask could be created by filling process only,
which resulted in the exactly same contour as that of ROI and causeed no false cavity
elements.
•

Check if there are openings on the cortex

The checking of cortex opening was based on the observation that the outer cortex
contours of two adjacent image slices should be very similar. The openings of the cortex
of one image slice can be detected based on the WholeBoneMask of its adjacent image
slice. It was better to start the checking from the end of an image stack with smaller
cortex diameter (the first image slice) to the end with larger cortex diameter (the last
image slice). The cortex openings of the image slice with the slice number of N (current
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image slice) were checked based on the WholeBoneMask of the image slice with the slice
number of N-l (reference image slice).
ElemDiff consisted of the elements that covered by the WholeBoneMask of the
reference image slice but not covered by the filled current image (in green color in Figure
(f) in Figure 3-10 and Figure 3-11). The Euclidean distance map (EDM) (Figure (g) in

Figure 3-10 and Figure 3-11) was a distance transform, in which each element of
ElemDiff contained its distance to the nearest outline of WholeBoneMask of the
reference image slice.

(a) Reference slice
(slice

(b)
RefWBM:
WholeBoneMask of figure (a)

(e) Mask outline of figure (b)

(f) ElemDiff: Difference between
(b) and (d). The pixel (I, j) is in
green color, which is covered by
(b) but not covered by (d)

I

(g) shortest distance between the pixel
(i, j) and the mask outline. The Max
value of the distance map is 118.2074

o

t

Figure 3-10 An example to check openings on the cortex (There is an opening in the
current image slice)
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If the maximum value of The Euclidean distance map was greater than a pre-

selected value, DistMax, there was at least one opening on the cortex of the current image
slice. If the maximum value of EDM was not greater than DistMax, there was no
opening. The value of DistMax was decided by the operator according to his experience.
DistMax was determined by experience and was set as 20 in the rat tibia model.
The special case was at the very beginning when the openings in the first image
slice needed to be checked. In such case, the second slice was used as reference slice.

(a) Reference slice
(slice number: N-1)

(b) RefWBM: WholeBoneMask
of figure (a)

0.9
0.8
0.7

0.6

0.5
0.4
0.3
0.2

0.1

Ie) Mask outline of fiaure Ib)

(f) Difference between (b) and (d).
The pixel (I. j) is in green color.
which is covered by (b) but not
covered by (d)

(g) shortest distance between the
pixel (i. j) and the mask outline. The
max value of the distance map is 1

o

t

Figure 3-11 An example to check openings on the cortex (There is no opening in the
current image slice)

•

Dlustration of how to decrease false marrow if there are openings on the
cortex.
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To describe this clearly, a tenn, WholeBoneErodeDilateDiff, was introduced. If
WholeBoneErodeDilateDiff was equal to a number N, it meant that the dilated image of
ROI was eroded by N more pixels than the extent of dilating. For example, if the image
was dilated by the extent of20 pixels and WholeBoneErodeDilateDiffwas equal to 5, the
dilated image was eroded by the extent of 25 pixels. If the image was dilated by the
extent of 20 pixels and WholeBoneErodeDilateDiffwas equal to 0, the dilated image was
eroded by the extent of 20 pixels too, that is, erode the image to its original size (Figure
3-7c).
The setting of WholeBoneErodeDilateDiff that was greater than zero resulted in
smaller WholeBoneMask than the WholeBoneMask that was detennined by setting
WholeBoneErodeDilateDiff to

zero.

This

smaller WholeBoneMask,

called

as

WholeBoneMaskSmaller, resulted in a problem because it did not cover all elements of
ROI. To restore the uncovered ROI elements, WholeBoneMaskSmaller (Figure 3-12c)
was combined with the filled binary image ofROI (Figure 3-12b). The combined image
is shown in Figure 3-12d, in which the elements that are covered by both filled binary
image and WholeBoneMaskSmaller are in blue color, the elements that are covered by
filled binary image but not covered by WholeBoneMaskSmaller are in white color, the
elements that are covered by WholeBoneMaskSmaller but not covered by filled binary
image are in green color. The binary image (Figure 3-12e) that was converted from this
combined image was the desired WholeBoneMask.
By setting WholeBoneErodeDilateDiff greater than zero, the number of false
elements were decreased which resulted in the decreasing of false marrow. Figure 3-7c
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and Figure 3-12f showed the different results of WholeBoneMask with different setting
of WholeBoneErodeDilateDiff based on same 2DLBO.

Figure (d) Overlapping of
figure (b) and (c)

Figure (e) Whole Bone Mask

Figure (f) Cavities used to create
3D cavity model of WBROI
(WholeBoneErodeDilateDiff=5)

Figure 3-12 Better WholeBoneMask was created. No false elements existed in cavity
image (Figure f).

With the increasing value of WholeBoneErodeDilateDiff, the number of false
cavities decreased. How about the value of WholeBoneErodeDilateDiff was set too big?
There was an example that WholeBoneErodeDilateDiff was set to 40 (Figure 3-13). In
this case the WholeBoneMask was not good because some of marrow elements were not
covered by WholeBoneMask.
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Figure (d) Combination of
figure (b) and (c)

Figure (e) Binary image of
figure (d)

Figure (f) WholeBoneMask
by filling figure (e)

Figure 3-13 WholeBoneMask was not good if the value of WholeBoneErodeDilateDiff
was set too large.

A perfect WholeBoneMask should cover all elements of ROI (bone, marrow
cavity and cavities in cortex), and not cover any background elements. The optimal value
of WholeBoneErodeDilateDiff was such that it rarely resulted in false elements and that
it still resulted in a good WholeBoneMask. WholeBoneErodeDilateDiff was set to 5 in
this paper.
3) Accuracy improvement: cancellous bone segmentation
A few cortical bone elements that were located near boundary of the inner surface
of cortex and marrow region were treated as cancellous bone elements (Figure 3-8e and
Figure 3-8f) because of the effect of dilating and eroding process when CancellousMask
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was created. The dilated marrow region could be eroded a little more than the extent of
dilating to get better segmentation result.
To describe this clearly, a term, MarrowDiff, was introduced. If MarrowDiff was
equal to a number N, it meant that the dilated image of 2D marrow region was eroded by
N more pixels than the extent of dilating. For example, if the marrow region was dilated
by the extent of 20 pixels and MarrowDiff was equal to 2, the dilated image was eroded
by the extent of 22 pixels. If the image was dilated by the extent of 20 pixels and
MarrowDiff was equal to 0, the dilated image was eroded by the extent of 20 pixels too,
that was, erode the image to its original size (Figure 3-8d). MarrowDiff was set to a value
N that was greater than zero. Two values were assigned to MarrowDiff. One was
MarrowDiffS, which was a smaller value, and the other was MarrowDiffL, which was a
larger value. MarrowDiffS was set to 2 in this paper. The 2D marrow region (in red color
in Figure 3-14a) was dilated and then eroded by the extent that was 2 more pixels than
the extent of dilation. This step resulted in a cancellous mask, CancellousMaskS (in green
and blue color in Figure 3-14b). TrabS was the cancellous bone that was covered by
CancellousMaskS. MarrowDiffL was set to 6 in this paper. The separated 2D marrow
region (in red color in Figure 3-14a) was dilated and then eroded by the extent that was 6
more pixels than the extent of dilating. This step resulted in another cancellous mask,
CancellousMaskL (in green and blue color in Figure 3-14c). CancellousMaskl (in green
and blue color in Figure 3-14d) was formed by the elements that were covered by
CancellousMaskL and/or TrabS. CancellousMask (in green and blue color in Figure
3-14e) was the biggest part of CancellousMaskl. This step avoided the resulted in that
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some cortical bone elements that were located near the boundary of inner surface of
cortex and marrow region were treated as cancellous bone.

Figure (b)
green
blue color
and marrow in red color. TrabS (in blue color) was the
bone elements that were covered
Cancellous MaskS

Figure (a) Bone tissue image with marrow in red
color and bone in white color

Figure

Figure (d) CanceliousMask1 (in red, green and blue color)
was the combination of TrabS and CanceliousMaskL

blue color

Figure (e) CanceliousMask (in red, green and blue color)
was got by filling the biggest part of CanceliousMask1.
CortexTemp (in white color) was the bone elements that
were not covered by CanceliousMask2.

I
the
Figure (f) Cortical bone was
biggest part of a 3D model that was created by
stacking a series of contiguous 20 CortexTemp

Figure (h) Final segmentation result. Cortical bone was
shown in white color; Cancellous bone was shown in light
gray color; Marrow was shown in darker gray color;
Cavities in cortex was shown in darkest gray color

Figure (g) Cancellous bone was formed by
the bone elements that were not cortical
bone and were located inside Cortex3

Figure 3-14 CancellousMask and cancellous bone were determined with MarrowDiffS
2 and MarrowDiffL=6
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CortexTemp (in white color in Figure 3-14e) was formed by the bone elements
that were not covered by CancellousMask. Every image slice of the image stack had its
unique CortexTemp. The series of contiguous two-dimensional images of CortexTemp
were stacked to form a three-dimensional cortex model, CortexTemp3D. Cortical bone
was found by finding the largest object of CortexTemp3D. In CortexTemp3D it was
possible that there were some small bone objects that were not connected to main
structure because it was possible that some small cancellous bone objects were not
covered by CancellousMask. The biggest object of CortexTemp3D was cortical bone.
Cancellous bone was formed by the bone elements that were not cortical bone and were
located inside cortex.
The 3D version of the final segmentation result is shown in Figure 3-15. The 2D
version of the final segmentation result is shown in Figure 3-14h. Cancellous bone was in
light gray color. Cortical bone was in white color. The pixels with darker gray color were
marrow, and the pixels with darkest gray color were cavities in cortex. The pixels with
black color were background.

Figure (a) ROI

Figure (b) Cancellous bone

Figure (b) cortical bone

Figure 3-15 3D segmentation result
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3.5

AN IMPROVED METHOD OF BONEINON-BONE SEGMENTATION
(LOCAL GLOBAL THRESHOLD)
Generally, cortical bone has higher gray value than cancellous bone because of

beam hardening and partial volume effects in the thinner cancellous bone structures. A
single global threshold results in the loss of some cancellous bone. Two global thresholds
were used in the research. One was cortical bone threshold, which was used for cortical
bone identification. It was a single threshold that was detennined according to the
histogram of absolute gray values of all pixels that were covered by WholeBoneMask.
The other was cancellous bone threshold, which was used for cancellous bone
identification. It was a single threshold that was detennined according to the histogram of
absolute gray values of all pixels that were covered by CancellousMask.
The following sections described the algorithm steps in detail:
Step 1: Create a WholeBoneMask that was used to detennine cortical bone
threshold.
A global threshold for bone and non-bone tissue (bone/non-bone threshold) was
detennined slice by slice using the method ofOtsu (Otsu N, 1979). Instead ofconceming
all pixels of a single slice, only the pixels with non-zero gray values were used in the
decision of bone/non-bone threshold, which eliminated the influence of the black pixels.
A pixel was set as bone (white) if its gray value was greater than the threshold, otherwise
it was set as nonbone (black).
The largest bone object was found in the whole binary image stack by the
overlapping method that was described in Chapter 3.4. This largest bone object should be
part of the ROI. Since the global threshold method did not work well, some trabeculae
were not connected to the largest bone object. The loss of some trabeculae did not effect
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the creation of WholeBoneMask. The WholeBoneMask was created slice by slice using
dilating-filling-eroding method.
Step 2: Determine cortical bone threshold.
The cortical bone threshold was determined slice by slice using the method of
Otsu according to the histogram of absolute gray values of the pixels that were covered
by the WholeBoneMask. Every image slice had its own cortical bone threshold. The
cortical bone threshold was applied on its corresponding image slice. All pixels of the
whole image slice were set as bone or nonbone based on cortical bone threshold. A pixel
was set as bone if its gray value was greater than the threshold, otherwise it was set as
nonbone. The binary image created in step 2 had good cortical bone identification.
Because the relatively higher value of cortical bone threshold, some cancellous bone
pixels were set as nonbone.
Step 3: Determine cancellous bone threshold.
The CancellousMask was created by dilating-filling-eroding the marrow region
identified according to the binary image created in step 2. The Ccancellous bone
threshold was determined slice by slice using the method of Otsu according to the
histogram of absolute gray values of the pixels that were covered by the CancellousMask.
The cancellous bone threshold was applied on its corresponding image slice. All pixels
that were covered by CancellousMask were set as bone or nonbone based on cancellous
bone threshold.
Step 4: Create binary image.
The final binary image was created by the combination of the Figure 3-16e and
the Figure 3-16i. Figure 3-17 shows the bone/non-bone segmentation results from the
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local global threshold method and from the single global threshold method. Better
segmentation result was created by the local global threshold method.

Input

(a) CT imaQe

(b) Binary
image based
on a single
global
threshold

(c)WBM

Output

(d) Cortical bone
threshold based on
the histogram of
original gray values
of the pixels that are
covered by WBM

tIJ
0) Final binary
image is the
combination of
fig (e) and fig (i)

(f) Marrow
region

(g)
CanceliousMask

(h) Cancellous bone
threshold based on
the histogram of
original gray values
of the pixels that are
covered by
CanceliousMask

(il Binary
image of fig
(h) based on
cancellous
bone threshold

Figure 3-16 The illustration of the local global threshold method

Fig (a) CT image

Fig (b) Binary image created by
local global threshold

Fig (c) Binary image created by a
single global threshold

Figure 3-17 The comparison of the bone/non-bone segmentation results from the local
global threshold method and from the single global threshold method
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3.6

MECHANICAL PROPERTY ANALYSIS
The description of study objects that were used for mechanical property analysis

is illustrated in Table 3-1. Bone samples were fresh frozen in saline, thawed at room
temperature and carefully cleaned (muscles and tendons are removed) before preparation
and testing. All mechanical tests were performed on a servohydraulic load frame (MTS,
Bionix 858 test system).

3.6.1

Indentation test
Left tibiae were used for indentation tests. The cancellous bone surface that was

just below the growth plate was exposed for indentation test by trimming the top of the
proximal metaphysis off the bone sample. The trimming procedure allowed the
indentation force to be applied to each specimen at the same position.
The following sections described the indentation test in detail:
Step 1: Embed left tibia.
A container for epoxy resin (Bondo, Dynatron Corp, Atlanta) was combined by a
PVC Y2 inch cap (iIlller diameter was 22.3mm) and a plastic tube (outer diameter was
22.3mm, iIlller diameter was 17.7mm, length was 30mm). Before inserting the tube into
the cap, a small amount of WD-40 was placed on the iIlller bottom surface of the cap,
which made it easier to pull the tube off from the cap after Bondo hardened. The Bondo
was mixed with the hardener cream and stirred until well mixed. The Bondo was then
poured into the tube, stirred the Bondo again to make sure that the tube was filled by
Bondo and there were no air bubbles in the tube. The distal end of the tibia was placed
into the Bondo. The bone position was adjusted until it was perpendicular to the bottom
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surface of the cap. It was better to embed every bone in Bondo compound with the same
posture, so after trimming, the bone had similar exposed bone surface. After the Bondo
set, the tube was removed from the cap. The exposed portion of the tibia was kept moist
in saline soaked gauze until the bone was scanned.
Step 2: Scan the proximal metaphysis (Figure 3-18).
After embedding, the bone sample was scanned. The first CT slice was at the
position of the top point of the proximal tibia. Above and below growth plate, images
were made every 0.002 inch (0.0508mm). After scanning, the CT images were checked
and the image that represented the plane just below the growth plate was identified as the
trimming surface. The distance from the top of the proximal tibia to the trimming surface
was recorded.

Figure 3-18 The bone sample was embedded in Bondo and was CT scanned

Step 3: Trim the top part of the proximal metaphysic (Figure 3-19).
A low speed diamond saw (lsomet, Buehler, Lake Bluff, Illinois) was used to cut
the bone. First, the tube containing the bone was fixed into the pivoting mounting arm of
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the saw. With the blade turning, the top end of the bone was advanced toward the blade
until a noise was heard, indicating first contact with the blade. A cut was then made after
adjustment to set the position to the distance determined in step 2.

Figure 3-19 The top part of the proximal metaphysis was trimmed by the diamond saw

Step 4: Perform indentation test (Figure 3-20).
A cylindrical stainless steel indentor which was 1.5mm in diameter with a flat
bone-contacting tip was used. The platform holding the specimen was leveled to ensure
that the loading was perpendicular to the specimen surface to be tested. The sample was
positioned on the platform in such position that the indentor was driven into the middle of
the exposed cancellous bone surface. The indentor position was also carefully adjusted so
the indentor surface was very close to the bone surface but not touching the bone surface.
Then the indentor, descending at a rate of 2mm1min, compressed the exposed cancellous
bone surface until the cancellous bone failed. The actual compression force was recorded
every 0.001 second during the lowering of the top part of the fixture .
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Figure (b) Failure of indentation test

Figure (a) indentation test

Figure 3-20 Description of indentation test

The typical curve of compression load is shown in Figure 3-21. The indentation
force was the maximum compressive force that was recorded from the lowest point of the
force-displacement curve.

I nde ntation test
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Figure 3-21 Typical curve ofthe indentation result (Exp2, CRed)

3.6.2

Three-point bending test
The right femur was used for three-point bending test.
The following sections described the three point bending test in detail:
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Step 1: Scan right femur.
The right femur was used for three point bending test. Before the bone was
scanned, it was thawed at room temperature. The bones in Figure 3-22a were numbered
as bone 1, bone 2, ... , bone 6 from left to right. . The fixture (Figure 3-22a) had 6 slots.
There was 1 small plastic tube attached in slot 1 of the fixture, 3 small plastic tubes
attached in slot 3 of the fixture, and 5 small plastic tubes attached in slot 5 of the fixture.
Bone 1 was put in slot 1, bone 2 was put in slot 2, ... , bone 6 was put in slot 6. All these 6
bones were held on the fixture by rubber band and scanned together. It made scanning
more efficient to scan 6 bones at one time than scanning bones separately.

Figure (a)

Figure (b)

Figure 3-22 Description of ex vivo CT scanning

Because the grey scale of the rubber band was similar with that of the bone
material, the rubber band should be placed away from the middle part of the bone. The
middle of the right femur shaft was CT scanned by one rotation encompassing 107 slices
using a cone-bean scanning mode. The CT image of the middle of the shaft (image with
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number 54) was used to calculate the bone area, moment of inertia and maximum tensile
stress.
Step 2: Calculate cross-sectional area and area moment of inertia of the bone
sample.
Bone area was calculated by counting bone pixels. The line 00 ' shown in Figure
3-23c was the axis for calculation of the moment of inertia Ix, which was also the axis of
the bending. This was assumed to be the axis for the bending based on the geometry of
the test and the orientation of the femur. The point 0 was the centroid of the bone area.
The point 0' was picked up by observing the image that was opened by ImageJ. Ix was
calculated according to the formula: I x

=

fy dA , where dA is an elemental area, y is the
2

perpendicular distance from the axis x to the element dA.

Figure (a)

Figure (b)

Figure (c)

Figure 3-23 Illustration of Bone area and moment inertia calculation

Step 3: Perform three-point bending test (Figure 3-24).
The right femur was positioned on a fixture with the anterior side toward the
loader. Load was applied on the midpoint between two supports that were 12 mm apart.
The top part of the fixture was also carefully adjusted so the surface of the top part of the
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fixture was very close to the bone surface but not touching the bone surface. Then the top
part of the fixture, descending at a rate of 1mm/min, compressed the mid-shaft of the
bone until the bone failed. The actual compression force was recorded every 0.01 second
during the lowering of the top part of the fixture. The force applied on the bone was
continually recorded until complete fracture occurred.

Figure (a)

Figure (b)

Figure 3-24 Three point bending test and the typical curve ofthe test result

The bending force was recorded from the lowest point of the force-displacement
curve (Figure 3-25). Maximum tensile stress is equal to (F

* L * c) / (4 * Ix), where F is

the bending force, L is the distance between the two lower supports, c is the maximum
distance between the lower part of the bone and the bending axis, Ix is the moment of
inertia calculated in step 2.
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Three-point bending test
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Figure 3-25 Force-displacement Curve (Exp2, C_Green2)
3.6.3

Torsion test
Left femur was used for torsion test. The middle of the femur shaft was CT

scanned before the test. Torsion test is described in Figure 3-26.
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Figure 3-26 Torsion test

The distal and proximal marks were made on the femur, which decided how deep
to embed the distal and proximal ends of the femur into Bondo. Two PVC liz inch caps
were needed for each bone sample. One was the bottom cap which was used to hold the
distal end of the femur. The other was the top cap which was used to hold the proximal
end of the femur. The distal end of the femur was embedded in Bondo first. To make sure
that the bone sample remained aligned while the Bondo was hardened, the bottom cap
with Bondo was fixed on the bottom of MTS machine, and the middle shaft of the sample
was held by a plastic holder which was fixed to the top of the MTS machine. The plastic
holder was made in to keep the sample aligned during embedding. The actuator of the
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MTS machine was moved down until the distal end of the sample was embedded in
Bondo and the distal mark on the sample was reached. After the Bondo set, the sample
was removed from the MTS machine. Next the bottom cap was moved to the top side of
the MTS machine. The other cap was placed on the bottom side of the MTS machine and
filled with Bondo. The actuator was then lowered until the proximal end of the sample
was embedded in Bondo and the proximal mark on the sample was reached. After the
Bondo set, torque was applied on the sample at a displacement rate of 0.25 deg/sec till the
failure happened. The actual torque was recorded every 0.001 second. The typical curve
of torque is shown in Figure 3-27. The maximum torque was recorded from the highest
point of the torque-angle curve.
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Figure 3-27 The typical curve of the test result (Exp1, A_Blk)
3.6.4

Three-point breaking test
The right tibia was used for three-point breaking test. The testing was done

blinded with regard to the test groups. In Prodama Study, some details were different
from the test procedure that was described in Sturmer's paper (Sturmer EK et aI., 2005).

70

A few hours before the testing, the right tibiae were completely thawed at room
temperature. The soft tissues were carefully removed prior to the testing. The fibula was
separated from tibia at the synostosis. The proximal tibia epiphysis was removed to avoid
the movement of the proximal growth plate during the test. The tibia was placed on the
base stamp (Figure 3-28). There were three rounded edge-free notches (Imm deep; 2, 3,
or 4 mm in diameter) on the top of the base stamp. The proximal end of the tibia was put
in one of the notches. The roller stamp consisted of an aluminum roller and a V-shaped
support. The roller axle was fixed in the support and the support was connected to the
MTS machine. The roller was adjusted until it was close to the bone surface but not
touching the bone surface. The distance between the front surface of the support and the
center of the roller was 3 mm. A plate with flat plane was placed on the front surface so
the front surface of the support and the flat plane of the plate attached to each other
tightly. The position of the base stamp was adjusted till the end of the proximal tibia
touched the flat plane of the plate, which guaranteed that the distance between the end of
the proximal tibia and the center of the roller stamp was exactly 3 mm.
After a final visual check of the correct tibia position, the roller was lowered
slowly and carefully until an initial force of IN was reached. When the testing was
started, the roller moved down at the speed of 5mmls (In Sturmer's paper, the speed of
the feed motion was 50mmls). The trial was automatically ended by a displacement
change of I mm (In Sturmer's paper, the trial was automatically ended by a drop in
strength of>20N or a linear displacement of>2 mm).
A typical force-displacement curve for the tibia breaking test is shown in Figure
3-28e. Three parameters were analyzed: breaking force, breaking yield force, and
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breaking energy. The breaking force was determined from the top of the curve. The
compression force corresponding to 50% of maximum slope was determined as the
breaking yield force. The breaking energy was equal to the area under the force curve up
to the failure load. The failure load was found at the point where the curve started to drop
abruptly (almost vertical), which corresponded to the complete failure of the bone
sample.
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Figure 3-28 Three-point breaking test and the typical curve of the test result (Exp2,
G_Green)
3.6.5

Femoral density via Archimedes' principle
Right femurs were submerged in distilled water and fully hydrated under a

vacuum for 1 hr. Subsequently, the mass of each hydrated femur was obtained in air and
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when submerged in water. Densities were determined usmg Archimedes' Principle
according to the following formula: density

=

[mass of hydrated femur / (mass of

hydrated femur - mass of hydrated femur submerged in water)] x density of distilled
water at a given temperature (Keenan MJ, et aI., 1997).
The proximal and distal ends of the femur were comprised primarily of cancellous
bone, whereas the femoral diaphysis contained primarily cortical bone. Evaluation of the
density of each of these femoral regions may thereby increase the understanding of the
effect of a drug on each of these types of bone. The left femurs were separated into three
regions (proximal left femur, distal left femur, and left femoral diaphysis) using an
Isomet Low Speed Precision Sectioning Saw from Buehler Limited (Lake Bluff, IL) with
a diamond blade. Briefly, each femur was measured with a Cen-Tech Digital Caliper and
a cut was made from each end at 20% of the length of the femur plus half the width of the
blade. Subsequently, the bone marrow was washed out of the femoral diaphysis and the
Archimedes density for each of the three femoral regions was determined as described
above.

3.7

EX VIVO STRUCTURAL ANALYSIS
Ex vivo mocro-CT based structural analysis was used for Pradama Expl, Pradama

Exp2 and Pradama Exp 3.

3.7.1

Scanning design
The right tibia was used for ex vivo structural analysis in this study. Before the

bone was scanned, it was thawed at room temperature. For all bone samples of ExpI, Exp
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2 and some bone samples of Exp 3, the fibula, epiphysis and patella were removed
manually from the metaphysis, so the CT image contained metaphysis only. The other
bone samples of Exp 3 had intact epiphyses. They were just cleaned. The reason for the
difference in Exp3 was that it was found there was more damage to the metaphysis top
surface during the process of removing the epiphysis.
Six right tibiae were fixed to the fixture and scanned together, which was same to
what is shown in Figure 3-22. The proximal end of the tibiae should position at the
bottom of the fixture, which insured that VOls of all six bone samples were scanned in
fewer rotations. Five rotations, 107 slices per rotation, were taken from the top of the
proximal metaphysis into the tibial shaft.

3.7.2

Image segmentation process
The new segmentation method that was described in chapter 3.4 was applied here.

The VOl was chosen from the position that was 0.98mm (70 slices x 0.014mm) below
the lower end of the growth plate and extending 4.2 mm (300 slices x 0.014mm) distally
for Pradama Expl and Exp2. When the images were checked down into the distal part of
the right tibia from the proximal top of metaphysis, the lateral part of the cortex was
becoming separated from the main part. For Pradama Exp 3, the VOl was chosen from
the position where the lateral part was just separated from the main part and extending
200 slices distally.
The method was totally automatic if one criterion was met: there were no other
bones connected to the VOL For the bone samples of which the epiphysis and patella
were removed from metaphysis before they were scanned, there were no other bones in
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the CT original scannmg Images. For the bone samples that did not go through the
epiphyseal removal procedure, such as in Exp3, the VOl was chosen distally enough to
make sure that there were no other bones connected to the VOl in the CT original
scanning images. No pre-step was needed to separate metaphysis from other bones before
Cancellous and cortical bone segmentation. The whole image segmentation process was
totally automatic.

3.8

RESULTS ANALYSIS METHODS

3.8.1

Validation of cancellous bone segmentation method
1) The new method is objective
For a given image stack, the segmentation results will be same no matter how

many times the program is run. It is obvious that the new method is objective because the
segmentation is performed automatically by computer. By contrast, a manual method can
differ between trials and between different operators.
2) The new method is more accurate, precise and repeatable
Two right tibiae (one sham, one OVX) were collected from 37-week-old Sprague
Dawley female rats. The epiphyses were removed before scanning (Micro CT, ACTIS
150/225 system, BIR Inc., Lincolnshire, IL). Six image stacks were obtained by loading

and scanning the proximal metaphyses of each bone sample three times. Nominal
isotropic resolution was 14Jlm. Three operators segmented cancellous bone from cortical
bone manually. Each operator segmented one sham image stack and one OVX image
stack. The segmentation results from manual work were used as a "gold standard". The
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new method was used to segment the six image stacks. The Helterbrand method was used
to segment the six image stacks.
1) Accuracy validation: The mean values of the cancellous bone volume
measured by three different methods were compared by Tukey multiple comparison, 2)
Precision validation: The coefficient of variation (CV) of each method was calculated as
CV= 1OO*(Standard deviation)/(mean value of set) . The smaller the value of the CV, the
more precise the method is, and 3) Repeatability validation: The variances of each
method were compared by F-test to determine whether the repeatability of the new
method was better than the manual method.

3.8.2

Data analysis of Alendronate study
Alendronate study was analyzed by P-value of statistical analysis that was

ANOVA followed by Post-hoc t-test (Tukey mUltiple comparisons). The drug effect was
evaluated by comparing the results at week 12 and week 16 with it own baseline at week
8. The drug effects were also compared with OVX group at the same time point (at week
12 and week 16).

3.8.3

Data analysis of the Pradama Study in engineering perspective
Two groups were analyzed: Sham group and OVX group.
1) Sensitivity analyses
The new methods (volume fraction, indentation testing, three-pt breaking testing)

were compared to the old methods (Archimedes and 3-pt bending testing). The new
methods were expected to be more sensitive to detect the differences between OVX and
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Sham. By focusing on only two groups at the same time points (11 weeks or 12 weeks),
simple t-tests (two-sample assuming unequal variances) was used to compare the mean
values for the various measurements and calculate p-values for each. Statistical power
and % difference were calculated if there is significant difference between sham and
OVx. % difference = «Sham - OVX) I Sham) * 100.
The p-values of the followings parameters were picked up by one tail t-test:
BVlTV from 3D image analysis, density from Archimedes method, Indentation force,
breaking force, and breaking yield force. The p-values of the followings parameters were
picked up by two tail t-test: Breaking energy, bending force, moment of inertia, area, and
maximum tensile stress.
The comparisons of new methods versus old methods were: 1) Volume fraction
vs. Archimedes, 2) Indentation testing vs. Archimedes, 3) Three-pt breaking testing vs.
Archimedes, 4) Volume fraction vs. three-pt bending testing, 5)Indentation testing vs.
three-pt bending testing, and 6) Three-pt breaking testing vs. three-pt bending testing.
2) Linear regression analyses
Finally, as another evaluation of the newly described bone quality measurements
developed in this dissertation work, the image processing method was correlated to the
mechanical test methods. In this way, the most significant linear correlations, if good
enough, could allow the transition from mechanical testing as the gold standard of bone
quality measurement to image analysis as a standard method. This would permit the use
of in vivo analysis and more powerful longitudinal studies.
It was expected that there were better relationship between indentation results and

cancellous bone volume fraction instead of whole bone volume fraction and cortical bone
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volume fraction, because indentation testing evaluated the mechanical competence of
cancellous bone directly.
It was expected that there was a better relationship between 3-pt breaking results

and whole bone volume fraction instead of cancellous bone volume fraction and cortical
bone volume fraction, because 3-pt breaking testing evaluated the mechanical
competence of whole bone as a composite of cancellous and cortical bone at the
metaphysis.

3.8.4

Data analysis ofPradama Study (drug effect)
Drug effects on osteoporosis were shown by P-value of statistical analysis as

ANOVA followed by post-hoc t-test (Tukey multiple comparisons) for individual image
analysis and mechanical testing. It was not the focus of this dissertation

3.8.5

Description ofP-value of statistical analysis
ANOVA, Post-hoc t-test (Tukey multiple comparisons), F-test, and regression

analysis were used in the research. A P value < 0.05 was considered to be statistically
significant. The P value less than 0.05 were in bold. A P value greater than 0.05 and less
than 0.1 was followed by *.
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CHAPTER 4. RESULT

4.1

CANCELLOUS BONE SEGMENTATION
Table 4-1 and Figure 4-1 are the cancellous bone volumes (mm3) of the sham

sample and the OVX sample.

Table 4-1
methods

Cancellous bone volume (mm3) calculated from different segmentation
Sham (n=3)
OVX (n=3)
Manual New Helterbrand Manual New Helterbrand
1.14
1.15
1.47
2.08
2.07
2.47
1.27
1.17
1.80
2.12
2.51
2.37
1.20
2.10
2.57
1.18
1.65
2.15

Cancellous bone volume (OVX)
2 .,------------

Cancellous bone volume (sham)

3-r-----------2.5 + - - - - - - - -

1.5 + - - - - - - - -

2
1

1.5

0.5

0.5

o

o
Mamal

New

Helterbrand

Manual

Figure 4-1 The results of cancellous bone volume (mm
methods

3

)

New

Hel terbrand

from different segmentation

The P-values in Table 4-2 were calculated based on the results of the sham
sample. The cancellous bone volume calculated from Helterbrand method was
significantly different from the cancellous bone volume calculated from manual method
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and also significantly different from the cancellous bone volume calculated from the new
method. There was no significant difference between the cancellous bone volume
calculated from manual method and that from the new method.

Table 4-2 the comparison of the means (cancellous bone volume of the sham sample)
between different segmentation methods
New
Helterbrand
Manual
0.3901
0.0125
Helterbrand 0.0031

The new method resulted in the smallest coefficient of variation (CV). The CVs
were around 1% for the new method, pointing to a good precision of the method (Table
4-3).
Table 4-3 The coefficient of variation (CV) of each method (%)
Manual

6.7

I
I

sham
New

1.1

OVX

I Helterbrand
I 1.9

Manual

5.6

I
I

New

0.9

I Helterbrand
I 10.1

The P-values in Table 4-4 were calculated based on the results of the OVX
sample. The cancellous bone volume calculated from Helterbrand method was
significantly different from the cancellous bone volume calculated from manual method
and also significantly different from the cancellous bone volume calculated from the new
method. There was no significant difference between the cancellous bone volume
calculated from manual method and that from the new method.

Table 4-4 the comparison of the means (cancellous bone volume of the OVX sample)
between different segmentation methods
New
Helterbrand
0.9016
I Manual
0.0050
I Helterbrand 0.0033
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Both the sham sample and the OVX sample showed that the new method resulted
in statistically smaller variance than the manual method (Table 4-5).

Table 4-5 The comparison of the variances between manual segmentation method and
the new method

ALENDRONATE STUDY

4.2

All images and data were referenced to week 8. Alendronate Study was designed
for the drug recovery experiment, that is, the bone needed to be lost first, then the drugs
were given to see if the bone mass was increased. Week 8 was the time point on which
the large bone loss was observed. The bone volume fractions of the different group are
shown in Figure 4-2.

ewe

Cane elkJ us bone BV frV
0.6

.W12

0.5

eWltl

0 .4

-_ _ _-_

-

.. ...

0 .1

I--

o

.. _--

Sh am

I--

It It

r-

I--

avx

Alen

E2

PTH

OW10

0.5
0.4

l-

.W12

0.6

03
01

owe

Whole bane BVITV
0.7

~

03

I--

Dl

I--

0 .1

I--

o
Sham

Pol kJ x

-

I-

avx

Alen

l-

I-

I--

I--

I--

I--

I--

I-E2

PTH

PoIIQX

Figure 4-2 Bone volume fraction results of Alendronate study

All OVX rats, including the four treatment groups, were significantly different
from Sham at all time points (P<0.05), with the exception of Alen_ W16 (0.31 ± 0.027) (P
value is 0.9914) (Table 4-6).
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Table 4-6 P-value of statistical analysis of cancellous bone volume fraction (with sham
data)
E2E2PTHPTHRalox- RaloxAlen
Alen
W12
W12
W16
W16
W12
W16
W12
W16
Alen W8
1.0000 0.9108
E2 W8
0.0798 0.0200
PTH W8
0.9111 0.5685
Ralox W8
0.2128 0.0381
OVX W12 0.0910*
1.0000
1.0000
1.0000
OVX W16
1.0000
0.9738
1.0000
0.0001
Sham W12 0.0017
0.0001
0.0001
0.0001
0.0001
Sham W16
0.9914
0.0001
0.0001

Comparing the cancellous bone volume fractions without considering the Sham
group, the E2 group and the Ralox group showed the significant decrease of the
cancellous bone volume fraction at week 12 and week 16 when they compared with their
own references at week 8 (E2_W8 and Ralox_W8, respectively), with the exception of
Relox_W12 (P value was 0.0706) (Table 4-7). The cancellous bone volume fraction of
Alen_W12, Alen_W16, PTH_W12 and PTH_W16 were not significantly different from
their baselines (Alen_ W8 and PTH_W8, respectively). Of all groups, Alen group was the
only group that showed increased cancellous bone volume fraction in the region of
interest.

Table 4-7 P-value of statistical analysis of cancellous bone volume fraction (without
sham data)
RaloxRaloxPTH
Alen
Alen
E2E2PTH
W12
W16
W12
W16
W12
W16
W12
W16
1.0000 0.7179
Alen W8
0.0200 0.0038
E2 W8
0.7185 0.2926
PTH W8
0.0706* 0.0082
Ralox W8
0.9999
0.9996
0.9999
OVX W12 0.0236
0.8741
1.0000
1.0000
OVX W16
0.0000
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All OVX rats, including the four treatment groups, were significantly different
from Sham at all time points (P<0.05), with the exception of Alen_W12 (0.53 ± 0.010) (P
value was 0.9790), Alen_W16 (0.58 ± 0.029) (P value was 0.9978) and PTH_W16 (0.46
± 0.049) (P value was 0.0666) (Table 4-8).

Table 4-8 P-value of statistical analysis of whole bone volume fraction (with sham data)
Alen
PTHPTHAlen
E2Ralox- RaloxE2W12
W16
W12
W12
W16
W16
W12
W16
Alen W8
0.9482 0.0357
E2 W8
1.0000 1.0000
1.0000 1.0000
PTH W8
Ralox W8
0.9998
0.9844
1.0000
OVX W12 0.1053
1.0000
1.0000
1.0000
0.9687
1.0000
OVX W16
0.0001
Sham W12 0.9790
0.0034
0.0016
0.0136
0.0666*
Sham W16
0.9978
0.0086
0.0021

Comparing the whole bone volume fraction without considering the Sham group,
the Alen group, E2 group, PTH group and Ralox group at week 12 and week 16 were not
significantly different from their own references (Alen_W8, E2_W8, PTH_W8 and
Ralox_W8, respectively), with the exception of Alen group at 16 weeks (P=0.0133)
(Table 4-9).

Table 4-9 P-value of statistical analysis of whole bone volume fraction (without sham
data)
RaloxPTH
PTH
Ralox
Alen
E2Alen
E2W12
W16
W12
W16
W16
W12
W12
W16
0.8486 0.0133
Alen W8
1.0000 1.0000
E2 W8
1.0000 1.0000
PTH W8
Ralox W8
0.9981
0.9368
1.0000
OVX W12 0.0449
0.9999
1.0000
0.8949
1.0000
OVX W16
0.0000
0.9995
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4.3

SENSITIVITY ANALYSES

4.3.1

Pradama Exp1 (Week 11)
Table 4-10 is the summery of the sensitivity study results ofPradama Exp1. There

were not significant differences detected in cancellous bone volume fraction, cortical
bone volume fraction, whole bone volume fraction, breaking energy, bending force,
moment of inertia, maximum tensile stress, torsional force, and whole bone density by
Archimedes's method (Keenan MJ et aI, 1997). There were statistically significant
differences between OVX and sham in indentation force, breaking force, breaking yield
force, and cross-sectional area. Comparing the OVX group with the Sham group, the
difference of cross-sectional area was 5.2%, while the differences were 73.2% in
indentation force, 41.6% in breaking force and 52.3% in breaking yield force.

Table 4- 10 Prad ama Exp 1 out comes
Sham (n=5)

OVX (n=3)

P value

Power

%
difference

Cc BV/TV (%)
8.80 ± 3.62
4.88 ± 0.50
0.0761 *
CtBV/TV (%)
46.76 ± 2.15
46.41 ± 4.42
0.9050
WBV/TV (%)
49.02 ± 4.39
51.45 ± 2.50
0.4434
In F (N)
39.98 ± 11.32
10.71 ± 1.77
0.8179
73.2
0.0048
BkF (N)
116.98 ± 10.89
68.29 ± 7.80
41.6
0.9907
0.0003
Bk YF (N)
112.34 ± 11.48
53.54 ± 3.31
0.9996
52.3
0.0001
BkE (N*mm)
28.49 ± 5.54
23.28 ± 2.07
0.1166
Bd F (N)
148.29 ± 11.60
160.15 ± 6.61
0.1149
Mal (mm4)
5.78 ± 0.48
5.38 ± 0.20
0.7279
Area (mm:!)
5.61 ± 0.11
5.91 ± 0.02
0.0041
0.8473
-5.2
MTS (MPa)
138.55 ± 6.49
137.50 ± 3.82
0.7819
Ts F (N)
0.32 ± 0.13
0.25±0.16
0.5783
W D (g/cmJ)
1.41 ± 0.01
1.43 ± 0.02
0.3214
Note: All values are expressed as mean ± SD. Cc: cancellous bone; Ct: cortIcal bone; W:
whole bone sample; In: indentation testing; F: Force; Bk: 3-pt breaking testing; YF: yield
force; E: energy; Bd: 3-pt bending testing; Mal: Moment of Inertia; MTS: Maximum
tensile stress; Ts: torsion testing; D: Density.
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Estrogen deficiency did not result in significant changes in the bone volume
fractions (Figure 4-3).
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Figure 4-3 Bone fraction results ofExp 1 from 3D image analysis.

Figure 4-4 shows the mechanical bone strength of the cancellous bone of the left
tibia. The indentation force for the OVX group (10.71 ± 1.77) was significantly lower
than that of the Sham group (39.98 ± 11.32) (P<O.Ol). There was a substantial decrease in
the indentation force by 73.2% in the OVX animals.
I mentation Fore e (N)
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Figure 4-4 Indentation testing results of Exp 1.
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OVX operation significantly decreased the breaking force (116.983 ± 10.889 for
sham and 68.29 ± 7.80 for OVX) (P<O.OOl) and breaking yield force (112.34 ± 11.48 for
sham and 53.54 ± 3.31 for OVX) (p=0.001) (Figure 4-5). The breaking force of OVX
group decreased 41.6% and the breaking yield force of OVX group decreased 52.3%.
There was a mild, but insignificant effect of OVX on breaking energy (Sham: 28.49 ±
5.54; OVX: 23.28 ± 2.07).
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Figure 4-5 Three-point breaking testing results ofExp 1.

The bending force, moment of inertia and maximum tensile stress of the cortical
bone in the femoral mid-diaphysis showed very little changes because of estrogen
deficiency (Figure 4-6). Only the cross-sectional area of femoral mid-diaphysis was
significantly different and it was higher in the OVX group versus the Sham group by
5.2%.
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Figure 4-6 Three-point bending testing results of Exp 1

The torsion force was 21.5% lower in OVX group (0.25 ± 0.16) versus Sham
group (0.32 ± 0.13) but not significant due to the large standard deviation of each group
(Figure 4-7).
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Figure 4-7 Torsion testing results ofExp 1
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Figure 4-8 shows the results of the whole bone density (right femur) that was
measured by the Archimedes method. There was no significant difference in the whole
bone density between the OVX group (1.41 ± 0.01) and the Sham group (1.43 ± 0.02).
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Figure 4-8 Density results of Exp 1 by Archimedes method

4.3.2

Pradama Exp2 (Week 11)
Table 4-11 is the summery of the sensitivity study results of Pradama Exp2. There

were not significant differences detected in cortical bone volume fraction, breaking
energy, bending force, moment of inertia, cross-sectional area, maximum tensile stress
and middle bone density. There were statistically significant differences between OVX
and sham in cancellous bone volume fraction, whole bone volume fraction, indentation
force, breaking force, breaking yield force, proximal bone density, distal bone density,
and whole bone density. Comparing the OVX group and the Sham group, the differences
of densities detected by Archimedes's method were 4.2% - 4.9%, while the differences
were 72.5% in cancellous bone volume fraction, 73 .0% in indentation force, 31.4% in
breaking force and 42.3% in breaking yield force.
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Table 4- 11 Prad ama Exp.2 out comes
Sham (n=6)

OVX(n=6)

P value

Power

%
difference
72.5

Cc BV/TV (%)
26.34 ± 5.98
7.24 ± 2.85
0.99999
0.0002
CtBV/TV (%)
45.99 ± 3.31
0.7359
46.64 ± 3.18
49.88 ± 3.80
WBV/TV(%)
62.24 ± 6.46
0.9527
19.9
0.0037
10.90 ± 3.68
In F (N)
40.32 ± 6.35
1.0000
73.0
0.00001
BkF (N)
102.64 ± 15.33
70.45 ± 17.85
31.4
0.0073
0.8548
BkYF (N)
88.64 ± 17.68
51.10± 10.16
0.0020
0.9815
42.3
BkE(N*mm)
29.10 ± 10.02
24.19 ± 5.47
0.3206
Bd F (N)
180.90 ± 16.38
194.52 ±19.67
0.2218
MOl (mm'l)
6.05 ± 0.83
0.9301
6.09 ± 0.80
Area (mmL)
0.6234
6.49 ± 0.35
6.40 ± 0.26
0.058
159.78 ± 7.54
MTS (MPa)
145.92 ± 13.37
Pro D (glcm.:l)
1.61 ±0.02
1.54 ± 0.02
4.5
0.0001 0.999969
Mid D (glcmJ)
1.81±1.13
1.75 ± 0.12
0.4278
Dis D (glcmJ)
1.40 ± 0.03
4.9
1.47 ± 0.02
0.0004
0.9970
WD (glcmJ)
4.2
1.53 ± 0.02
0.9367
1.59 ± 0.04
0.0037
Note: All values are expressed as mean ± SD. Cc: cancellous bone; Ct: cortical bone; W:
whole bone sample; In: indentation testing; F: Force; Bk: 3-pt breaking testing; YF: yield
force; E: energy; Bd: 3-pt bending testing; MOl: Moment of Inertia; MTS: Maximum
tensile stress; Pro: Proximal bone part; D: Density; Dis: Distal part.

The bone volume fractions are shown in Figure 4-9. There was a dramatic
reduction of the cancellous bone volume fraction for the OVX group (7.24 ± 2.85)
compared with the Sham group (26.34 ± 5.98) (P=O.OOOl), which is also shown clearly in
Figure 4-10. The cancellous bone volume fraction was diminished by 72.5% as a result of
the estrogen deficiency. The volume fraction of whole bone ofOVX group (49.88 ± 3.80)
was significantly lower than that of Sham group (62.24 ± 6.46) by 19.9%. There was not
significant difference in the volume fraction of cortical bone between the two groups
(46.64 ± 3.18 for sham and 45.99 ± 3.31 for OVX).
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Figure 4-9 Bone fraction of Exp 2 from 3D image analysis

Pretreatment Sham

Sham

Pretreatment OVX

OVX

Figure 4-10 Three-dimensional images (Exp2) of the tibial metaphysis of an OVX and
sham-operated animal (mean from each group) at the time of week 0 and week 11 after
operation: all images are aligned manually using VGStudio MAX to illustrate the internal
cancellous bone structure.

The indentation force by testing cancellous bone revealed a dramatic reduction for
the OVX group (10.90 ± 3.68) compared with the Sham group (40.32 ± 6.35)

(P=O.OOOOI) (Figure 4-11). The cancellous bone strength was diminished by 73.0% as a
result of the estrogen deficiency.
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Figure 4-11 Indentation testing results of Exp 2

The breaking force of the OVX group (70.45 ± 17.85) was significantly lower
than that of the Sham group (102.64 ± 15.33) by 31.4% (P<O.OOl) (Figure 4-12).
Moreover, the breaking yield force for the OVX group (51.10 ± 10.16) was significantly
lower than that of the Sham group (88.64 ± 17.68) by 42.3% (P=0.001). The breaking
energy of OVX was slightly lower than that of Sham group but not significant different.
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Figure 4-12 Three-point breaking testing results ofExp 2
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All measured parameters (bending force, moment of inertia, area, and maximum
tensile stress) of the cortical bone in the femoral mid-diaphysis were not significantly
different between the OVX group and Sham group (Figure 4-13).
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Figure 4-13 Three-point bending testing results of Exp 2

Figure 4-14 reveals the reduction for the OVX group compared with the Sham
group. The densities were all significantly lower in OVX group versus Sham group
except the density of middle bone part. Due to the estrogen deficiency, the density of
whole bone decreased by 4.2%, the density of proximal bone part decreased by 4.5% and
the density of distal bone part decreased by 4.9%.
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Figure 4-14 Density results ofExp 2 by Archimedes method

4.3.3

Pradama Exp3 (Week 12)
Table 4-12 is the summery of the sensitivity study results ofPradama Exp3. There

were statistically significant differences between OVX and sham in cancellous bone
volume fraction, whole bone volume fraction, indentation force, breaking force, breaking
yield force, breaking energy, and whole bone density. There were not significant
differences in cortical bone volume fraction, bending force, moment of inertia, crosssectional area, maximum tensile stress, proximal bone density, middle bone density and
distal bone density. Comparing the OVX group and the Sham group, the greatest
difference of the densities detected by Archimedes's method was 3.1 %, while the
differences were 55.8% in cancellous bone volume fraction, 86.4% in indentation force,
36.3% in breaking force and 47.5% in breaking yield force.
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T a bl e 4 - 12 P radama Exp.3 out comes
Sham (n=6)

OVX(n=7)

P value

Power

%
difference
55.8

11.86 ± 3.29
Cc BV/TV(%)
26.84 ± 3.05
0.000004
1.0000
CtBV/TV(%)
42.23 ± 3.29
43.31 ± 2.39
0.5230
WBV/TV(%)
57.79 ± 1.93
50.08 ± 1.34
0.00002
1.0000
13.3
37.94 ± 13.30
5.16 ± 1.59
In F (N)
0.999865
86.4
0.0018
101.38 ±16.86
64.59 ± 5.38
BkF (N)
0.997262
36.3
0.0022
Bk YF (N)
89.60 ± 18.14
47.08 ± 6.81
0.99874
47.5
0.0016
BkE (N*mm)
25 .29 ± 4.08
19.63 ± 5.06
0.4797
22.4
0.047
189.32 ±16.31
200.31 ± 17.95
0.2721
Bd F (N)
MOl (mm4)
5.34 ± 0.41
5.72 ± 0.79
0.2886
Area (mm L )
6.18 ± 0.23
6.34 ± 0.30
0.3108
173 .51 ± 11.98
169.30 ± 8.04
MTS (MPa)
0.4690
Pro D (glcmJ)
1.55 ± 0.04
1.53 ± 0.02
0.3272
Mid D (g/cmJ)
1.66 ± 0.05
1.63 ± 0.02
0.22.7
J
1.42
±
0.03
1.39
±
0.04
0.2270
Dis D (gI_cm )
W D (glcmJ)
1.55 ± 0.01
1.60 ± 0.02
0.0026
0.9863
3.1
Note: All values are expressed as mean ± SD. Cc: cancellous bone; Ct: cortical bone; W:
whole bone sample; In: indentation testing; F: Force; Bk: 3-pt breaking testing; YF: yield
force; E: energy; Bd: 3-pt bending testing; MOl: Moment of Inertia; MTS : Maximum
tensile stress; Pro: Proximal bone part; D: Density; Mid: Middle bone part; Dis: Distal
bone part.

The 3D structures of the cancellous bone are shown in Figure 4-15.
Pretreatment sham

Sham

Pretreatment OVX

OVX

Figure 4-15 Three-dimensional images (Exp3) of the tibial metaphysis of an OVX and
sham-operated animal (mean from each group) at the time of week 12 after operation: all
images were aligned manually using VGStudio MAX to illustrate the internal cancellous
bone structure.

The differences of the volume fractions between the OVX group and the Sham
group in Exp3 were similar to those in Exp2, but the magnitudes of the differences in Exp
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3 were less than those in Exp 2. The cancellous bone volume fraction of the OVX group
was significantly lower than that of the Sham group by 55.8% in Exp 3 instead of by
72.5% in Exp2. In both Exp 2 and Exp 3, the cortical bone volume fraction showed no
significant difference between the OVX group and the Sham group.
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Figure 4-16 Bone fraction ofExp 3 from 3D image analysis

All mechanical properties (breaking force, breaking yield force, breaking energy)
evaluated by breaking testing revealed a significant reduction in the OVX group
compared with the Sham group. The decreases of breaking force, breaking yield force
and breaking energy were 36.3%, 47.5% and 22.4%, respectively, as the result of
estrogen deficiency.
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Figure 4-17 Three-point breaking testing results of Exp 3

Figure 4-18 shows the mechanical strength of cancellous bone assessed by
indentation testing. The bone strength for the OVX group (5.16 ± 1.59) was significantly
lower than that of the Sham group (37.94 ± 13.30) by 86.4% (P<O.OOl).
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Figure 4-18 Indentation testing results of Exp 3
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The measured properties of cortical bone showed no significant changes because
of estrogen deficiency (Figure 4-19). The cross-section area showed a mild increase in
the OVX group versus that in Sham group by 2.6%, but not significant.
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Figure 4-19 Three-point bending testing results of Exp 3

Although all densities of different bone parts showed the decrease due to the
estrogen deficiency, there were not significant differences in densities of regional bone
parts (Proximal, middle and distal) (Figure 4-20). Only the density of whole bone
revealed the significant decrease in the OVX group versus Sham group by 3.1 %.
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Figure 4-20 Density results of Exp 3 by Archimedes method

4.4

LINEAR REGRESSION ANALYSES
For Exp2, there were 6 data points for BV/TV parameters in group E2_Wll

instead of 7 data points because one right tibia in group E2_Wll was destroyed before
CT imaging.

4.4.1

Indentation testing vs. volume fraction
In Exp 2, indentation force was highly correlated with cancellous bone volume

fraction (R2 = 0.569, P = 0.000) and whole bone volume fraction (R2 = 0.503, P = 0.000)
(Figure 4-21). The R2 of the correlation between indentation force and cortical bone
volume fraction was only 0.245. There was a little fewer statistically significant
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correlation between indentation force and whole bone volume fraction than was found
between indentation force and cancellous volume fraction.
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Figure 4-21 Regression analysis ofExp2: Indentation force vs. BV/TV

In Exp 3, indentation force was highly correlated with cancellous bone volume
fraction (R2 = 0.542, P = 0.000) and whole bone volume fraction (R2 = 0.588, P = 0.000)
(Figure 4-22). There was not significant correlation between indentation force and
cortical bone volume fraction. There was a little fewer statistically significant correlation
between indentation force and cancellous bone volume fraction than was found between
indentation force and whole bone volume fraction.
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Figure 4-22 Regression analysis ofExp3: Indentation force vs. BV/TV

The R2 of the correlation between cancellous bone volume fraction and cortical
bone volume fraction was only 0.245 in Exp2 (Figure 4-23). Cancellous bone volume
fraction was highly correlated with whole bone volume fraction (R2 = 0.852, P = 0.000).
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Figure 4-23 Regression analysis of volume fractions (Exp2)

The R2 of the correlation between cancellous bone volume fraction and cortical
bone volume fraction was only 0.218 in Exp3 (Figure 4-24). Cancellous bone volume
fraction was highly correlated with whole bone volume fraction (R2 = 0.503, P = 0.000)
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Figure 4-24 Regression analysis of volume fractions (Exp3)
4.4.2

Three-pt breaking testing vs. volume fraction
In Exp2, The R2 of the correlation between the breaking force and cancellous

bone volume fraction was only 0.293 (Figure 4-25). The R2 of the correlation between the
breaking force and whole bone volume fraction was 0.377. The R2 of the correlation
between the breaking force and whole bone volume fraction was 0.424.
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Figure 4-25 Regression analysis ofExp2: Breaking force vs. BV/TV
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Figure 4-26 demonstrates a significantly positive correlation between the breaking
force and cancellous bone volume fraction (R2

=

0.504, P

0.000) in Exp3. A

=

significantly positive correlation was also demonstrated between the breaking force and
whole bone volume fraction (R2 = 0.552, P

=

0.000). No significant correlation between

the breaking force and cortical bone volume fraction was found (R2 = 0.001, P
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Figure 4-26 Regression analysis ofExp3: Breaking force vs. BV/TV

In Exp2, the R2 of the correlation between the breaking yield force and cancellous
bone volume fraction was 0.306 (Figure 4-27). The R2 of the correlation between the
breaking yield force and whole bone volume fraction was 0.356. The R2 of the correlation
between the breaking yield force and cortical bone volume fraction was 0.347.
In Exp3, the correlation between the breaking yield force and cancellous bone
volume fraction was significant (R2

=

0.542, P

=

0.000) (Figure 4-28). The correlation

between the breaking yield force and whole bone volume fraction was also significant
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(R2 = 0.552, P = 0.000). No significant difference was found for the correlation among
breaking yield force and cortical bone volume fraction.
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Figure 4-27 Regression analysis of Exp2: Breaking yield force vs. BVlTV
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Figure 4-28 Regression analysis ofExp3: Breaking yield force vs. BVITV
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In Exp2, the R2 of the correlation between the breaking energy and cancellous

bone volume fraction was only 0.142 (Figure 4-29). The R2 of the correlation between the
breaking energy and whole bone volume fraction was 0.286. The R2 of the correlation
between the breaking energy and cortical bone volume fraction was 0.206.
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In Exp3, the R2 of the correlation between the breaking energy and cancellous
bone volume fraction was only 0.179 (Figure 4-30). The R2 of the correlation between the
breaking energy and whole bone volume fraction was 0.286. There was no significant
correlation between breaking energy and cortical bone volume fraction.
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Figure 4-30 Regression analysis ofExp3: Breaking Energy vs. BV/TV

4.5

PRADAMA DATA ANALYSIS (DRUG EFFECT)
The results from Exp3 were used here to illustrate the drug effects on OVX rat

models. One right femur from OVX_W6 was destroyed before three-point bending
testing, so there were 5 bending force data and 5 maximum tensile stress data instead of 6
data. Table 4-13 is the P-value of statistical analysis results of the drug effect by
ANONA.
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. resu Its b Y ANOVA (E xp 3)
T abi e 4- 13 D rug e fIiec t P -va ue 0 f st afIS flca1 ana1YSlS
P value (with sham data)
P value (Without sham data)
BV/TV (Cancellous) (%)
0.000
0.035
BV/TV (Cortical) (%)
0.068*
0.063*
BV/TV (Whole) (%)
0.000
0.000
Indentation Force (N)
0.000
0.010
Breaking Force (N)
0.000
0.000
Breaking Yield Force (N)
0.000
0.000
Breaking Energy (N*mm)
0.000
0.000
Bending Force (N)
0.010
0.009
Moment of Inertia (mm4)
0.039
0.036
Area (mm2 )
0.019
0.020
Max Tensile Stress (MPa)
0.003
0.001

Figure 4-31 shows the charts of the bone volume fractions calculated by image
analysis method. The 3D structure of cancellous bone is shown in Figure 4-32.
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Figure 4-31 Bone fraction ofExp 3 from 3D image analysis
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Figure 4-32 Three-dimensional images (Exp3) of the tibial metaphysis of an OVX and
sham-operated animal (mean from each group) at the time of week 12 after operation: all
images were aligned manually using VGStudio MAX to illustrate the internal cancellous
bone structure.

The cancellous bone volume fraction of all OVX rats, regardless of treatment,
were significantly different form those of sham at week 12. Estrogen deficiency caused
significantly decrease in cancellous bone volume fraction at week 6 and week 12 (Table
4-14).

Table 4-14 P-value of statistical analysis (Exp3) of drug effect on cancellous bone
volume fraction (with sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6 0.0026
Sham W12
0.0000
0.0007
0.0137
0.0010
OVX W6
0.6949
0.9985
0.7657
0.0327
OVX W12
0.6445
0.1112
0.5647
E2 W12
0.9337
1.0000
Alen W12
0.9621
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Cancellous bone volume fractions with drugs (E2, Alen, PTH) were not
statistically different from OVX at week 12 (Table 4-15). There were no statistical
differences between drug effects.

Table 4-15 P-value of statistical analysis (Exp3) of drug effect on cancellous bone
volume frac tion (without sham data)
OVX W12 E2 W12 Alen W12 PTH W12
OVX W6 0.0271
0.5519
0.9868
0.6239
OVX W12
0.5039
0.0841*
0.4325
E2 W12
0.8375
1.0000
Alen W12
0.8880

Table 4-16 does not show any significant effect of the estrogen deficiency on
cortical bone volume fraction.

Table 4-16 P-value of statistical analysis (Exp3) of drug effect on cortical bone volume
fraction (with sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6
0.9494
Sham W12
0.8012
0.4465
0.2191
0.9965
0.527
0.2168 0.0881*
OVX W6
0.9336
0.482
0.9775
0.7686
OVX W12
E2 W12
0.9969
0.9433
Alen W12
0.9993

Cortical bone volume fractions with drugs (E2, Alen, PTH) were not statistically
different from OVX at week 12 (Table 4-17). There was no statistically different between
drug effects.

Table 4-17 P-value of statistical analysis (Exp3) of drug effect on cortical bone volume
fraction (without sham data)
OVX W12 E2 W12 Alen W12 PTH W12
0.1522 0.0631 *
0.3891
OVX W6
0.8316
0.9179
0.6171
0.352
OVX W12
E2 W12
0.9781
0.8485
Alen W12
0.9919
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Estrogen deficiency caused significant decrease in whole bone volume fraction at
week 6 and week 12 (Table 4-18).

Table 4-18 P-value of statistical analysis (Exp3) of drug effect on whole bone volume
fraction (with sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6
0.0000
0.7391
Sham W12
0.4007
0.0000
0.0175
0.9953
0.1352
0.3601
OVX W6
0.0677* 0.0002
OVX W12
0.0011
0.4072
0.7455
E2 W12
0.9978
Alen W12

Whole bone volume fractions with drugs (E2, Alen, PTH) were statistically
different from OVX at week 12 (Table 4-19). There were not statistical differences
between drug effects.

Table 4-19 P-value of statistical analysis (Exp3)
fraction (without sham data)
OVX W12 E2 W12
0.9656
0.1470
OVX W6
OVX W12
0.0363
E2 W12
Alen W12

of drug effect on whole bone volume
Alen W12
0.0742*
0.0002
0.2518

PTH W12
0.2180
0.0007
0.5506
0.9794

Figure 4-33 shows the mechanical strength of cancellous bone assessed by
indentation testing. Estrogen deficiency caused significant decrease in indentation force
at week 6 and week 12 (Table 4-20). At week 12, the bone strength for the OVX group
(5.159 ± 1.594) was significantly lower than that of the Sham group (37.936 ± 13.303) by
86.4% (P<0.05).
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Figure 4-33 Indentation testing results ofExp 3

Table 4-20 P-value of statistical analysis (Exp3) of drug effect on indentation force (with
sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6 0.0030
0.1015
0.0022
0.0274
Sham W12
0.0002
OVX W6
1.0000
0.9252
0.9996
OVX W12
0.9953
0.6801
0.3269
E2 W12
0.9631
0.7412
Alen W12
0.9975

The indentation forces with drugs (E2, Alen, PTH) were not statistically different
from OVX_W12, with the exception ofPTH_W12 (Table 4-21). There were no statistical
differences between drug effects.

Table 4-21 P-value of statistical analysis (Exp3) of drug effect on indentation force
(without sham data)
OVX W12 E2 W12 Alen W12 PTH W12
OVX W6 0.0622*
0.4207
0.9991
0.9647
OVX W12
0.8497
0.1061
0.0133
0.1456
E2 W12
0.5686
Alen W12
0.8939

Figure 4-34 shows the mechanical strength of whole bone assessed by three-point
breaking testing.

110

d

Breaking Yield Fort:e (N)

Brelilking Force (N)
lIID , - - - - - - - - - - - -

14O~-----------~

+-::::-------------j
+-:::lc---,.-----------j

140
120
100

120

~r-------------..j

100

80

Bo

110

110
40

40

20

20

o

o
'1M2

PTH
Brelilking Energy (Nom m)
"0 ......-........-.-.... -... --... --.-.-~- . ,., , ,,, -~~--~-""--""""-"'5D~r----------~

4D~r------------r~

30
20
10

o

Figure 4-34 Three-point breaking testing results ofExp 3

Estrogen deficiency caused significant decreases in the breaking force at week 6
and week 12 (Table 4-22).

Table 4-22 P-value of statistical analysis (Exp3) of drug effect on breaking force (with
sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6 0.0005
0.3763
0.9974
Sham W12
0.0010
0.0029
0.0705*
0.9931
0.7727
OVX W6
OVX W12
0.2228
1.0000
0.0052
E2 W12
0.3619
0.0134
Alen W12
0.7253

PTH treatment resulted in a significant increase of the breaking force reaching
values above the OVX_W12, and E2_W12 groups (Table 4-23). E2 and Alendronate
treatments did not show significant effect on breaking force.
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Table 4-23 P-value of statistical analysis (Exp3) of drug effect on breaking force
(without sham data)
OVX W12 E2 W12 Alen W12 PTH W12
OVX W6
0.8201
0.9305
0.4537
0.0138
OVX W12
0.9991
0.0619*
0.0007
E2 W12
0.1244
0.0019
Alen W12
0.3988

Estrogen deficiency caused significant decreases in the breaking yield force at
week 6 and week 12 (Table 4-24).

Table 4-24 P-value of statistical analysis (Exp3) of drug effect on breaking yield force
(with sham data)
OVX W6 OVX W12 E2 W12 Alen W12
PTH W12
Sham W6 0.0000
Sham W12
0.0510*
0.0000
0.0006
0.9399
OVX W6
0.9928
0.2672
0.0018
OVX W12
0.1320
0.9518
0.0005
E2 W12
0.6648
0.0118
Alen W12
0.3896

PTH treatment resulted in a significant increase of the breaking yield force
reaching values above the OVX_ W12, and E2_ W12 group (Table 4-25). Alendronate
also significantly increased the breaking yield force. In contrast, E2 treatment did not
show significant effect on breaking yield force.

Table 4-25 P-value of statistical analysis (Exp3)
(without sham data)
OVX W12 E2 W12
0.9960
0.9079
OVX W6
OVX W12
0.7180
E2 W12
Alen W12
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of drug effect on breaking yield force
Alen W12 PTH W12
0.0506*
0.0001
0.0172
0.0000
0.2668
0.0007
0.0952*

Estrogen deficiency caused insignificant decreases in whole bone volume fraction
at week 6 and week 12 (Table 4-26).
Table 4-26 P-value of statistical analysis (Exp3) of drug effect on breaking Eng (with
sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6
0.1062
Sham W12
0.8255
0.6290
1.0000
0.1328
OVX W6
0.9011
0.9998
0.0418
OVX W12
0.8955
0.9996
0.0037
E2 W12
0.7251
0.0019
Alen W12
0.0956*

At week 12, PTH was the only treatment that resulted in a significant increase of
the breaking energy compared to the OVX (Table 4-27).

Table 4-27 P-value of statistical analysis (Exp3) of drug effect on breaking Eng (without
sham data)
OVX W12 E2 W12 Alen W12 PTH W12
0.6852
0.9939
OVX W6
0.8909
0.0105
0.6747
OVX W12
0.9907
0.0008
0.4391
0.0004
E2 W12
Alen W12
0.0276

Figure 4-35 shows the mechanical strength of cortical bone assessed by threepoint bending testing.
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Figure 4-35 Three-point bending testing results ofExp 3

Estrogen deficiency caused insignificant decreases in the bending force at week 6
and week 12 (Table 4-28).

Table 4-28 P-value of statistical analysis (Exp3) of drug effect on bending force (with
sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
Sham W6
0.9527
Sham W12
0.9762
0.9072
0.8099
1.0000
OVX W6
0.8800
0.0144
0.1741
OVX W12
0.4019
0.9973
0.9960
E2 W12
0.1815
0.8031
0_9118
Alen W12

At the same time point, no drug increased the bending force compared with OVX
group (Table 4-29).
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Table 4-29 P-value of statistical analysis (Exp3) of drug effect on bending force (without
sham data)
OVX W12 E2 W12 Alen W12 PTH W12
0.7532
0.1244
OVX W6
0.0315
0.0122
0.9742
OVX W12
0.2914
0.9800
E2 W12
0.1296
0.6580
Alen W12
0.7986

Estrogen deficiency caused insignificant decreases in the moment of inertia at
week 6 and week 12 (Table 4-30).

Table 4-30 P-value of statistical analysis (Exp3) of drug effect on moment of inertia
(with sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
1.0000
Sham W6
0.9424
0.2798
0.9681
0.9932
Sham W12
0.5482
0.8070
1.0000
OVX W6
0.0254
1.0000
0.5986
OVX W12
0.6774
E2 W12
0.0423
0.6910
Alen W12

E2 results in significant decrease in moment of inertia compared with OVX at
week 12 (Table 4-31).

Table 4-31 P-value of statistical analysis
inertia (without sham data)
OVX W12 E2 W12 Alen W12
0.7300
OVX W6
0.6558
0.4966
OVX W12
1.0000
0.0384
0.0579*
E2 W12
Alen W12

(Exp3) of drug effect on moment of
PTH W12
0.9997
0.5394
0.6083
0.6205

Estrogen deficiency caused insignificant decreases in the cross-sectional area at
week 6 and week 12 (Table 4-32).
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Table 4-32 P-value of statistical analysis (Exp3) of drug effect on cross-sectional area
(with sham data)
OVX W6 OVX W12 E2 W12 Alen W12 PTH W12
0.9995
Sham W6
0.2700
0.7025
1.0000
Sham W12
0.9809
0.4166
0.5273
1.0000
OVX W6
0.9830
0.9423
0.0404
OVX W12
0.3738
E2 W12
0.0075
0.5749
Alen W12

All treatment groups did not show any significant change in cross-sectional area
compared with OVX at week 12 (Table 4-33).

Table 4-33 P-value of statistical analysis (Exp3)
(without sham data)
OVX W12 E2 Wl2
OVX W6 0.8504
0.3769
0.0523*
OVX W12
E2 W12
Alen W12

of drug effect on cross-sectional area
Alen W12 PTH W12
1.0000
0.4688
0.9481
0.8804
0.3418
0.0133
0.5091

Estrogen deficiency caused insignificant decreases in the maximum tensile stress
at week 6 and week 12 (Table 4-34).

Table 4-34 P-value of statistical analysis (Exp3) of drug effect on
stress (with sham data)
OVX W6 OVX W12 E2 W12 Alen W12
0.8521
Sham W6
0.9934
0.9990
0.76l3
Sham W12
0.0042
0.0306
OVX W6
0.9390
1.0000
OVX W12
0.9838
E2 W12
Alen W12

maximum tensile
PTH W12
0.9195
0.0104
0.9929
0.9998
0.9993

No statistically significant changes of treatments in maximum tensile stress were
observed compared with OVX at week 12 (Table 4-35).
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Table 4-35 P-value of statistical analysis (Exp3) of drug effect on maximum tensile
stress (without sham data)
OVX W12 E2 W12 Alen W12 PTH W12
OVX W6 0.0085
0.0007
0.0065
0.0020
OVX W12
0.7530
0.9990
0.9349
E2 W12
0.8901
0.9940
Alen W12
0.9860
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CHAPTER 5. DISCUSSION

5.1

CANCELLOUS BONE SEGMENTATION METHOD
The new segmentation method offers a fast, automatic means to segment

cancellous bone from cortical bone, and has the ability to determine the cavities in cortex
automatically and objectively. Although the original image stacks (from computed
tomography or MRI) provide 3D information, previous segmentation approaches are
based on the 2D information of each single image slice and perform segmentation slice
by slice according to this 2D information, which ignores the relationships between
different slices. The difficulty of segmentation also comes from the complex structure of
bone and the existence of the holes in the cortex. In some cases, it is difficult to know
whether a cavity in a single image slice is a cavity in the cortex or a part of the marrow
cavity. The insufficient information provided by the original image stack results in
segmentation errors and limits the previous segmentation methods to be valid only in
specific conditions. Unlike previous techniques, the method illustrated in this dissertation
takes advantage of the 3D nature of the information, which is shown to have the
advantage of giving more precise and accurate segmentation results.
If the ROI is connected to other bones in a single image stack, manual
preprocessing is needed to delete the other bones from the ROI. An in-house program
was created by Matlab for this purpose. The method is based on the observation that
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cancellous bone is surrounded by a continuous marrow regIOn and cortical bone is
outside of this marrow region. The accurate designation of the marrow region is critical
to the success of the method. There are three factors that affect the designation of marrow
region: image quality, bone/non-bone segmentation and the definition of the
WholeBoneMask.
Because trabeculae are very small, the present method requires high resolution of
the original image stack so trabeculae can be separated from marrow. Higher image
resolution leads to higher radiation dose and/or longer scanning times, which should be
considered in in vivo study.
The segmentation of bone and non-bone is also critical. It is possible that cavities
in the cortex are defined as marrow if the bone elements that are located between the
cavities and the marrow are treated as non-bone elements, which leads to overestimation
of the marrow region. Conversely, some marrow regions may be excluded from the
definition of the main marrow region if a nonbone region appears to be disconnected
from the main structure of marrow because of overestimation of the bone compartment.
The marrow region is the largest 3D cavity among the cavities found in the ROI.
The cavities are defined by finding non-bone elements that are covered by the
WholeBoneMask. In this dissertation, a dilating-filling-eroding method is used to create
the WholeBoneMask if there are one or more cortex openings in a single image slice.
Since the dilation smoothes the edges of the image, the outer contour of the
WholeBoneMask is not exactly the same as that of the bone image, which causes false
cavities along the outer surface of the bone compartment. If the false cavities are
connected to the marrow region, they are false marrow and result in the inaccurate
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definition of the marrow region. False marrow is on the image slices adjacent to or near
the image slices with openings in the cortex. Since the segmentation is carried out based
on the information of the marrow region, inaccurate definition of the marrow region
causes errors in segmentation. Perfect WholeBoneMask is such that its contour is the
same as that of the outer surface of cortex, so no false marrow exists. Different methods
may be needed to find perfect WholeBoneMask for specific bone sample.
It works theoretically to find the largest object by the whole matrix method.

However, the size of the 3D matrix, that is, the size of the bone sample, is limited to
computer memory. To avoid this problem, the overlapping method was developed.
Instead of handling the whole 3D matrix, overlapping method handles two image slices at
one time, which results in more memory efficiency than the whole matrix method.
MarrowDiffL determines which bumps on the inner surface of cortex will be
treated as trabeculae. MarrowDiffS delimits where to cut the trabeculae off. The value of
MarrowDiffL and MarrowDiffS are determined by the bone structure in the study and are
suggested to keep unchanged in a single longitudinal study, so no longitudinal error
caused by these two parameters is involved.
There is no statistically significant difference between the segmentation results
from the new method and those from a manual method, which demonstrates the accuracy
of the new automatic segmentation method. However, the results calculated by the
He1terbrand method are significantly different from those calculated by the manual
method and by the new method. Using the manual work as gold standard, the new
method is more accurate than the He1terbrand method.
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The precision and repeatability of the new method are excellent. The precision of
the new method is very high, ranging around 1%. The variance of the new method is
statistically significantly smaller than that of the manual method, which means that the
repeatability of the new method is better than the manual work. Theoretically, for a given
image stack, the segmentation results will be the same no matter how many times the
program is run if the program is totally automatic. The variance of the new method comes
only from the scanning procedure: a single bone sample was loaded and scanned three
times. The three data sets are not identical even though they come from the same bone
sample because a bone sample cannot be fixed in the holder in exactly the same position
twice.
In conclusion, the new method is more accurate than a previously published
method (Helterbrand's method), and more precise and more repeatable than the manual
method. The advantages of the method are: 1. It is automatic, accurate, precise and
repeatable; 2. The segmentation is dependent on the bone architecture only, no
assumption is needed; 3. The method has the potential to do segmentation even when the
whole bone sample has complex structure and irregular shape; 4. The cavities in the
cortex can be detennined automatically and accurately. The prerequisite of the method is
the high resolution of the image so that marrow region and cancellous compartment can
be separated from each other.
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5.2

ALENDRONATE STUDY
The volume fraction of the region of interest at week 0 approached 0.5 due to the

young age of the rats and the ongoing growth and modeling of immature bone near the
metaphysis. This also did not allow adequate registration of the serial images to include
week O.
OVX results in the negative basic multicelluar units (BMUs) balance. It produces
a net loss of bone from the skeleton with each remodeling event, which leads to the
decrease of bone volume fraction. However, greater rates of bone loss and structural
decay are more likely to be due to differences in remodeling rate than due to differences
in remodeling imbalance (Seeman E, 2007). The situation may be explained by the
regional difference of response to estrogen deficiency. It is well known that estrogen
deficiency results in much greater bone loss in cancellous bone than in cortical bone. For
the same bone volume, cancellous bone has much more bone surface than cortical bone,
which indicates much greater remodeling rate in cancellous bone. Greater bone loss in
cancellous bone reflects, at least partially, the greater influence of remodeling rate than
the negative BMU balance.
This may explain the striking outcome of this study: alendronate causes such a
large positive response in cancellous bone. The rats used in this study are 7-8 weeks old.
The young animals are still growing rapidly and it is possible that the OVX operation
results in higher remodeling rate in young animals. When anti-resorptive drug is given,
the individuals with high baseline remodeling rate have more positive response than those
with low baseline remodeling rate. The study of Greenspan et ai. (Greenspan S et aI.,
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2006) showed that increases in BMD in those with a higher remodeling rate exceeded
increases in BMD in those with low remodeling.
The dependence of the remodeling rate before treatment explains the effect of the
young animals on the experimental results. The magnitude of increase of the bone
volume fraction is also likely dependent on the inhibitory effect of the drug on resorption.
Alendronate suppresses remodeling more than raloxifene (Allen Met aI., 2006; Johnell 0
et aI., 2002). The stronger the inhibitory effect of the drug on resorption, the greater the
positive outcomes resulted by the drug. This is also supported by the experimental results
of Alendronate Study. Based on the dose and schedule used in this study, it is clearly
shown that alendronate resulted in significant higher cancellous bone volume fraction
than E2. It may be temping to conclude that alendronate has stronger inhibitory effect
than E2 based on the experimental results of this Alendronate Study, but it needs be
explored in future studies.
In Alendronate Study, alendronate has more positive effects on cancellous bone
volume fraction than PTH as used in the young rat model. Because limiting the dose and
frequency of PTH has some theoretical advantages, particularly with regard to cost (i.e.
approximately US$7200 per year for daily injections of PTH (Rosen CJ, 2004) and
US$635 drug cost per year of alendronate (Mobley LR et aI, 2006)), combination therapy
provides more economic choices. Rittmaster RS et ai. (2000) have reported that
postmenopausal osteoporotic women, who have been treated with alendronate given
sequentially for 1 year after recombinant human PTH-(1-84) therapy, responded with an
overall increase of 14.6% at the spine together with significant improvement in the
femoral neck and total body calcium. Another possibility is that PTH was not given often
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enough in Alendronate Study. PTH was administered only three times per week whereas
other studies administered PTH more frequently (Baumann BD et aI, 1995; Mosekilde L
et aI., 1995).
In summary, alendronate results in a greater increase of cancellous bone volume
fraction than PTH in the model with high remodeling rate. Because the therapy of PTH is
much more expensive, combination therapy of PTH followed by alendronate maybe a
more economic choice as well as a more effective approach.

5.3

SENSITIVITY ANALYSIS
A novel indentation test method was developed during the Pradama Exp 1. The

animal samples of Pradama Exp 1 were used to improve testing methods for the
indentation testing and three-point breaking testing. Although exciting results in the Exp 1
were obtained, the results of Exp 1 were not very reliable because the Exp 1 was more like
a practicing. The sensitivity analysis was therefore based on Exp2 and Exp3.
A major drawback of the rat model is that rats continue to grow and do not ever
completely fuse the epiphyses. This problem can be overcome by selecting cancellous
bone sampling sites that are remodeling. For female Fischer rat model, the longitudinal
bone growth in the proximal tibiae is 9.98J.!m1day at 6 months old and 3.3J.!m1day at 9
months old (Erben RG et aI., 1996). In a 12-week (84 days) study, the proximal tibial
growth will add less than 0.84 mm of new bone. Although the skeleton of Fischer rats
may be more mature than skeleton in rat strains with a higher growth capacity, e.g.,
Sprague-Dawley or Wistar rats at a given age (Erben RG et aI., 1996), the analysis with
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ROI that begins at one mm distal to the growth plate of proximal tibia should be safe to
avoid any new bone growth.
In both Exp2 and Exp3, there were no statistically significant differences between
OVX and sham in the measurements of mid shaft of femur (bending force, moment of
inertia, cross-sectional area and maximum tensile stress). The differences of some density
measurements are detected and some not. For those densities with statistically significant
differences, the differences between OVX and sham are in the range of 3.1 %

~

4.9%.

Such small differences may be obscured because of issues of measurement precision,
which challenges the three-point bending testing and Archimedes's method to be valid
methods to evaluate OVX and treatment effects.
In Exp2, the difference in cancellous bone volume fraction between OVX and
sham was 72.5% while the difference in whole bone volume fraction between OVX and
sham was 19.9%. In Exp 3, the difference in cancellous bone volume fraction between
OVX and sham was 55.8% while the difference in whole bone volume fraction between
OVX and sham was 13.3%. No statistical significant difference in cortical bone between
OVX and sham was detected. Estrogen deficiency increases the rate of bone remodelling
and the negative bone balance in the BMUs. Remodeling occurs on bone surfaces. A
volume of bone constructed with cancellous bone has more surface upon which
remodeling can occur than the same volume of bone made up of cortical bone. Therefore,
more cancellous bone is lost after OVX than cortical bone, which explains the better
sensitivity of cancellous bone volume fraction to the differences between sham and OVX.
The indentation testing confirmed the dramatic effect of estrogen deficiency on
cancellous bone in terms of corresponding changes in mechanical properties. OVX
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resulted in 73.0% decrease in indentation force in Exp2 and 86.4% decrease in Exp3.
Since there was little or no effect of estrogen deficiency on the cortical bone properties,
which has been shown in the three-point bending testing, the excluding of cortical bone
in the measurement increased the sensitivity in detecting changes of mechanical
properties due to OVX or treatments.
The breaking testing measured mechanical properties of the whole bone of the
proximal tibia metaphsis. The percent differences between sham and OVX obtained from
the three-point breaking tests were about half of those from the indentation testing. The
presence of cortical bone greatly reduced the sensitivity to detect changes in bone quality.
The difference in cancellous bone volume fraction between OVX and sham in
Exp2 was greater than that in Exp3. Considering the fact that the distal part of the
proximal metaphysis of tibia lost more cancellous bone after OVX operation, the result
was not surprising because more distal part was included in the VOl of Exp2 than Exp3
(the VOl of Exp2 consisted of three hundred slices while the VOl of Exp3 consisted of
two hundred slices).
Longer period of estrogen deficiency results in a greater bone loss. Because the
indentation testing was performed at week 11 after OVX in Exp2 and week 12 after OVX
in Exp3, it was not surprising that more difference was detected in indentation force in
Exp 3 than in Exp2.
There have been many studies to explore the mechanical properties of cancellous
bone by indentation testing. Some of these studies have identified regional variations of
mechanical properties (Katoh T, et aI., 1996; Aitken GK, et aI., 1985; Sumner DR, et aI.,
1994; Dunham CE et aI., 2005). The bone samples for the studies, such as human patella,
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distal human tibia, human humerus and adult male mongrel dog tibia, need to be big
enough for the regional information. Indentation testing has also been used on small bone
samples, like the rat model. An YH et al. (1997) reported the mechanical properties of rat
epiphyseal cancellous bone. The indentation testing has also been used to evaluate
mechanical properties of cancellous bone in the distal femoral metaphysis of rats (Shen V
et aI., 1995; Meng XW et aI., 1996; Ke HZ et aI., 1998). In Ke's study, OVX for 30 and
60 days induced significant decreases in the indentation force (-75%, and -82%,
respectively) of cancellous bone as compared with sham controL Meng also reported the
significantly lower load in OVX rats than in the sham animals. In all these previous
studies, the exposed cancellous bone surface was completed by cutting the bone from the
upper surface to a certain depth or by cutting directly proximal to the femoral condyle.
Because the indentation testing results are very sensitive to the position of the exposed
cancellous bone surface, the testing protocol is superior than other studies by providing
consistent cuts with the help of CT scanning.
One other test method introduced in a previous study that indeed loaded only
cancellous bone was the "reduced-platen" compression, which used platen sized and
aligned to load only cancellous bone in the center of the sample (Hogan HA, et aI., 2000).
The maximum force, stiffness and energy absorbed were all diminished by roughly 60%
as a result of the effect of35 days ofOVX on 14-week-old female Sprague-Dawley rats.
This approach requires the cancellous bone surface on both top and bottom sides of the
test specimens. In some cases when cancellous bone loss is severe, it is possible that there
are just a few trabeculae or no cancelllous bone on the bottom surface, which causes
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trouble in the testing. In addition, the cutting position of exposed cancellous bone in
Hogan's method was not sufficient.
Despite the promising results, the indentation testing protocol has its limitations.
Specimen preparation is labor-consuming because of the bone embedding, CT scanning,
saw-cut positioning and finally, cutting. Since the same indentor was used during the
tests for all bone samples, the potential artifact introduced by the presence of the cortical
bone that remains attached to the specimen during testing is different for different bone
samples: the smaller the cross-area of the exposed cancellous surface, the greater the
potential artifact. Unfortunately, the extent of this effect is unknown. This potential
artifact was minimized by using a 1.5mm indentor, several times smaller than the
metaphysis.
In summary, the changes of the mechanical properties of cancellous bone in the
proximal tibia of the rat in different groups can be detected by the indentation testing; the
evaluation of the whole bone properties at the proximal metaphysis can help people
understand more about osteoporosis fracture. Based on the results and comparison with
conventional methods (three-point bending testing, densities by Archimedes's method),
the new methods (Cancellous bone volume fraction, indentation testing, three-point
breaking testing) introduced here are more sensitive and useful to capture the changes in
small bones of rat model.

128

5.4

LINEAR REGRESSION ANALYSIS
The selection of the ROI was better in Exp2 than in Exp3 because the start point

of the ROI was more consistent in Exp2. In Exp2, A region located 0.98 mm (70 slices

*

0.014 mm/slice) from the lower end ofthe growth plate and extending 4.2 mm (300 slices

* 0.014 mm/slice) distally was chosen for evaluation. In Exp3, the ROI was chosen from
the position where the lateral part of the cortex was just separated from the main part and
extending 2.8 mm (200 slices * 0.014 mmlslice) distally.
The bone/non-bone segmentation was better in Exp3 than in Exp2. The global
threshold method was used slice by slice to segment bone from nonbone in Exp2. The
regional global threshold method was used slice by slice to segment bone from nonbone
in Exp3. The better bone/non-bone segmentation resulted in better cortical and cancellous
bone segmentation and finally better calculation of bone volume fraction. Due to some
unknown reasons of scanning procedure, the lightness of the image slices changed a lot in
a single image stack, which resulted in a wrong decision during bone/non-bone
segmentation if the global threshold method was used. Moreover, since the cortical bone
had higher gray values than cancellous bone, the global threshold method tended to lead
to a bone/non-bone segmentation with thicker cortex and lost cancellous bone. These
problems produced some poor results of cancellous and cortical bone segmentation, and
finally some poor results of bone volume fraction. The regional global threshold method
overcomes the problem of the lightness changing within a single image stack. In addition,
regional global threshold method gave better decisions of cortical bone and cancellous
bone definition than the global threshold method.
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Because the bone/non-bone segmentation method had more effect on bone
volume calculation than ROI selection, the results of Exp3 were considered closer to the
real case and were used to explore the relationships between mechanical properties and
bone volume fractions.
The indentation force was positively correlated with cancellous bone volume
fraction and whole bone volume fraction. The R2 (0.542) of the correlation between the
indentation force and the cancellous bone volume fraction was a little lower than that
(0.588) between the indentation force and the whole bone volume fraction. Because the
indentation force was applied on the cancellous bone, it was expected that there would be
better relationship between indentation results and cancellous bone volume fraction
instead of whole bone volume fraction. One explanation to this phenomenon was that the
whole bone volume fraction was also correlated with cancellous bone volume fraction
(R2=0.503). The bone loss or bone growth will happen on all parts of bone instead of
some specific parts of bone. The second explanation to this phenomenon was the
selection of the cancellous bone volume. The indentation force was applied on the
cancellous bone surface that was just below the growth plate. The cancellous bone
volume used in Exp3 was chosen lower than the growth plate. It is reasonable to predict
the better correlation between the indentation force and the cancellous bone volume
fraction if the cancellous bone volume was just below the growth plate, which needed to
be confirmed in the future study. In addition, although the indentation force was applied
on cancellous bone surface, the cancellous bone was attached to the cortical bone during
the testing, which constrained lateral expansion of the loaded cancellous bone to some
extent. This stiffer response led to the potential artifact, so the indentation force was not
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only a response to the mechanical properties of the cancellous bone, but also to the
cortical shell.
There was no correlation between the breaking results and cortical bone volume
fraction. The breaking force was positively correlated with cancellous bone volume
fraction and whole bone volume fraction. The R2 (0.504) of the correlation between the
breaking force and the cancellous bone volume fraction was a little lower than that
(0.552) between the breaking force and the whole bone volume fraction. The yield
breaking force was also positively correlated with cancellous bone volume fraction and
whole bone volume fraction. The R2 (0.542) of the correlation between the breaking yield
force and the cancellous bone volume fraction was a little lower than that (0.552)
between the breaking yield force and the whole bone volume fraction. Since three-point
breaking testing evaluates the mechanical competence of whole bone, it was expected
that there were better relationship between three-point breaking results and whole bone
volume fraction instead of cancellous bone volume fraction and cortical bone volume
fraction, which was shown in this experiment.
Although there was correlation between the bone mechanical strength and bone
volume fraction, the R2 value of around 0.55 was not strong enough to support the
application of bone volume fraction alone to predict bone mechanical strength accurately.
It may be explained by engineering perspective that mechanical competence is not only

determined by the mass of the material but also determined by the spatial arrangement of
the material, and the quality of the material, neither of which were considered.
Pothuaud's study (Pothuaud L, et aI., 2002) showed that in combining both
morphological and topological explanatory powers, the normalized parameters were able
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to increase the prediction of the elastic moduli compared to the prediction of BVlTV
along. Shen (1995) also reported the mechanical strength was related to cancellous bone
volume and connectivity parameters. So it is reasonable to expect that adding other
structural parameters, such as trabecular thickness, trabecular number and trabecular
separation etc, may result in better prediction, which needs to be shown in future studies.

5.5

PRADAMA DATA ANALYSIS (DRUG EFFECT)
The treatment effects of Estrogen, alendronate and PTH have also been evaluated

here.
No drug significantly increased the cancellous bone volume fraction when
compared with OVX control (Table 4-15). But the indentation testing showed that PTH
resulted in the significant increase of mechanical strength of cancellous bone (Table
4-21). The discrepancy between the cancellous bone volume fraction and its mechanical
strength caused by PTH therapy could be explained by the improvement of the bone
structure or material. Previous studies (Sato M et aI., 1997; Shen V et aI, 1993) showed
that PTH improved connectivity in the proximal tibias and vertebrae. From a mechanical
perspective, this is easy to understand because the strength of a structure is not only
dependent on how much material is used to build the walls, but also dependent on the
spatial arrangement of the materials.
PTH has been shown by others to significantly increase the cross-sectional area of
cortical bone (Baumann BD et aI, 1995; Mosekilde L et aI., 1995). By contrast, Pradama
Study did not show any significant differences in cross-sectional area and moment of
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inertia. The different conclusions may be caused by the different treatment regimens.
PTH was injected 5 days per week at a dose of 0.08 mglkg BW in Baumann's study, 6
days per week at a dose of 0.08 mglkg BW in Mosekilde's study, but only 3 days per
week at a dose of 0.08 mglkg BW in Pradama Study. In addition, the tibia diaphysis was
evaluated in Baumann's study instead of the femur diaphysis, as in Pradama Study. The
different site-specific responses to PTH have also been reported in other studies (Neer
RM et aI, 2001). Neer reported that the daily subcutaneous injections of PTH (1-34)
increased bone mineral density by 9 and 13 more percentage points in the lumbar spine
and by 3 and 6 more percentage points in the femoral, while decreased bone mineral
density at the shaft of the radius by 2 more percentage points. Although the femur
diaphysis was also evaluated in Moselilde's study, the treatment was initiated at 17 weeks
of age in Moselilde's study and at 32 weeks of age in Pradama StUdy. The younger rat
model may have more anabolic response to PTH treatment.
Although Roschger (Roschger P et aI., 2001) reported that alendronate increased
the degree and uniformity of mineralization in cancellous bone of osteoporotic women,
there was no sign in Pradma Study that the intrinsic mechanical property (maximum
tensile stress) was affected by the changes of material properties (if there was any change
of material properties).
In the breaking tests, PTH significantly increased all measured parameters
(breaking force, breaking yield force, breaking energy) compared with the OVX control
group. Only breaking yield force was significantly increased by alendronate and no
measured parameters were significantly increased by estrogen when compared with OVX
control group. For the limited dosing that we investigated, the results of Pradama Study
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suggest that PTH is superior to alendronate and estrogen in the restoring the mechanical
strength in the proximal metaphysis of the rat tibia. However, it would be necessary to
study each drug over a wide range of doses to find the optimum dose for each drug
treatment. Then, when compared, the superiority of one drug over another may be
determined. Considering the facts that there were not significant differences in the whole
bone volume fraction between these three drug groups and the fact that PTH improved
the bone structure, Pradama Study confirms the commonly accepted opinions that the
bone volume fraction cannot predict the bone mechanical competence precisely. It is
better to evaluate the bone structure together with the bone volume fraction to help
people to understand the effect of osteoporosis and the treatments.
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CHAPTER 6. CONCLUSION

The new cancellous and cortical bone segmentation method can segment
cancellous bone from cortical bone automatically, accurately and precisely. There is no
statistically significantly different between the result from the new method and that from
the manual method. The variance of the results from the new method is significantly
lower than that from manual method;
Alendronate was the only treatment that resulted in increased cancellous bone
volume fraction and whole bone volume fracion in Alendronate Study, in which the
young animals were used. This result has interesting implications for the possibility of
early intervention to prevent osteoporosis while there is still enough remaining scaffold
of cancellous bone for significant recovery to be possible;
The more traditional methods (Archimedes density measurements and three-point
bending testing) show 5% or less differences between Sham group and OVX group. But
for the same animals, the new methods (volume fraction, indentation testing, three-point
breaking testing) can show up to 86% differences, indicating that the new methods are
much more sensitive to distinguish the differences between sham, OVX and different
drug treatments;
The correlations between indentation test and cancellous bone volume fracion,
and between breaking force and whole bone volume fraction, and between breaking yield
force and whole bone volume fraction are good. However, the correlation with R2 around
135
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0.55 is not strong enough to allow the sole application of bone volume fraction to predict
mechanical properties accurately. For this reason, other image parameters are needed for
the better correlation of destructive method using nondestructive method;
Bone volume fraction explains most of the differences in cancellous bone
strength. But the spatial arrangement of bone material and the tissue quality also play
important roles in bone quality. It is better to combine both image analysis and
mechanical tests to understand osteoporosis in cancellous bone.
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